activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650126	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2349	Homo sapiens	Kd		
Not Active	1650126	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2349	Homo sapiens	Kd		
	1650127	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2500.0	CHEMBL2349	Homo sapiens	Kd	uM	2.5
Not Active	1650128	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL2349	Homo sapiens	Kd		
	1650129	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	39.0	CHEMBL2349	Homo sapiens	Kd	uM	0.039
Not Active	1650130	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL2349	Homo sapiens	Kd		
Not Active	1650131	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL2349	Homo sapiens	Kd		
Not Active	1650132	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL2349	Homo sapiens	Kd		
Not Active	1650133	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL2349	Homo sapiens	Kd		
	1650134	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2000.0	CHEMBL2349	Homo sapiens	Kd	uM	2.0
	1651544	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.0	CHEMBL2349	Homo sapiens	Kd	uM	0.001
Not Active	1651545	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL2349	Homo sapiens	Kd		
Not Active	1651546	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL2349	Homo sapiens	Kd		
Not Active	1651547	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL2349	Homo sapiens	Kd		
Not Active	1651548	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL2349	Homo sapiens	Kd		
	1651549	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	480.0	CHEMBL2349	Homo sapiens	Kd	uM	0.48
Not Active	1651550	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL2349	Homo sapiens	Kd		
	1651551	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	6400.0	CHEMBL2349	Homo sapiens	Kd	uM	6.4
Not Active	1651552	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL2349	Homo sapiens	Kd		
	1651553	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	9500.0	CHEMBL2349	Homo sapiens	Kd	uM	9.5
Not Active	1651554	CHEMBL860795	Average Binding Constant for PHkg2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL2349	Homo sapiens	Kd		
	2081807	CHEMBL928831	Inhibition of PHKG2 at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL2349	Homo sapiens	Inhibition	%	20.0
	2147342	CHEMBL922027	Activity of human PhKgamma2 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	98.0	CHEMBL2349	Homo sapiens	Activity	%	98.0
	2182827	CHEMBL941453	Inhibition of PHKG2 at 5 uM	B	O=c1cc(N2CCOCC2)nc2c3ccccc3ccn12		CHEMBL179242	=	Inhibition	%	-6.0	CHEMBL2349	Homo sapiens	INH	%	-6.0
	2206860	CHEMBL990535	Inhibition of PHKG2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	39.0	CHEMBL2349	Homo sapiens	Kd	nM	39.0
	2470350	CHEMBL995029	Inhibition of PHKG2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2349	Homo sapiens	INH	%	10.0
Not Evaluated	2476718	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2478557	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2349	Homo sapiens	Activity		
	2478760	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	1.4	CHEMBL2349	Homo sapiens	Activity	%	1.4
Not Evaluated	2479615	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2349	Homo sapiens	Activity		
	2479818	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	21.6	CHEMBL2349	Homo sapiens	Activity	%	21.6
Active	2480615	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2480817	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2349	Homo sapiens	Activity		
	2511600	CHEMBL973454	Inhibition of PHKgamma2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	IC50	nM	0.1	CHEMBL2349	Homo sapiens	IC50	uM	0.0001
Not Evaluated	2577236	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2577439	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2593644	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2593910	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2594113	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2594853	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2595056	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2349	Homo sapiens	Activity		
	2596253	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	1.3	CHEMBL2349	Homo sapiens	Activity	%	1.3
Not Evaluated	2596456	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2349	Homo sapiens	Activity		
Not Evaluated	2597725	CHEMBL982746	Binding affinity to human PHKG2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2349	Homo sapiens	Activity		
	2721682	CHEMBL1054312	Inhibition of PhKgamma2 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	2899101	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899102	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899103	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899104	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899105	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899106	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899107	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	9000.0	CHEMBL2349	Homo sapiens	Kd	nM	9000.0
	2899108	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899109	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899110	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899111	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899112	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899113	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899114	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899115	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2900.0	CHEMBL2349	Homo sapiens	Kd	nM	2900.0
	2899116	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899117	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899118	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899119	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899120	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899121	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899122	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899123	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899124	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899125	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899126	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1400.0	CHEMBL2349	Homo sapiens	Kd	nM	1400.0
	2899127	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899128	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899129	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899130	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899131	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899132	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899133	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.14	CHEMBL2349	Homo sapiens	Kd	nM	0.14
	2899134	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	100.0	CHEMBL2349	Homo sapiens	Kd	nM	100.0
	2899135	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5.9	CHEMBL2349	Homo sapiens	Kd	nM	5.9
	2899136	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899137	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2899138	CHEMBL1037549	Binding constant for PHKG2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	2921219	CHEMBL1057584	Inhibition of PHKG2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	2938463	CHEMBL1041402	Inhibition of PHKgamma2 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	4.0	CHEMBL2349	Homo sapiens	INH	%	4.0
	2992233	CHEMBL1044536	Inhibition of human PHKG2 at 20 uM by FRET assay	B	C#Cn1c(C#CCCO)nc(-c2ccc(F)cc2)c1-c1ccncc1	Outside typical range	CHEMBL576620	=	Inhibition	%	-15.0	CHEMBL2349	Homo sapiens	INH	%	-15.0
	3052439	CHEMBL1070474	Residual activity of PHKG2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	53.0	CHEMBL2349	Homo sapiens	Residual activity	%	53.0
	3052691	CHEMBL1040268	Residual activity of PHKG2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	72.0	CHEMBL2349	Homo sapiens	Residual activity	%	72.0
	3054000	CHEMBL1050331	Residual activity of PHKG2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	88.0	CHEMBL2349	Homo sapiens	Residual activity	%	88.0
	3054252	CHEMBL1070474	Residual activity of PHKG2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	86.0	CHEMBL2349	Homo sapiens	Residual activity	%	86.0
	3055539	CHEMBL1040268	Residual activity of PHKG2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL2349	Homo sapiens	Residual activity	%	96.0
	3056844	CHEMBL1050331	Residual activity of PHKG2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	103.0	CHEMBL2349	Homo sapiens	Residual activity	%	103.0
	3057096	CHEMBL1070474	Residual activity of PHKG2 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	83.0	CHEMBL2349	Homo sapiens	Residual activity	%	83.0
	3058416	CHEMBL1040268	Residual activity of PHKG2 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	80.0	CHEMBL2349	Homo sapiens	Residual activity	%	80.0
	3059700	CHEMBL1050331	Residual activity of PHKG2 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL2349	Homo sapiens	Residual activity	%	93.0
	3214008	CHEMBL1116756	Inhibition of PHKgamma2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	-7.0	CHEMBL2349	Homo sapiens	INH	%	-7.0
	3224918	CHEMBL1100996	Inhibition of PHKgamma2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3226297	CHEMBL1100996	Inhibition of PHKgamma2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3332080	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3333495	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3334900	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3336320	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3337612	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3338943	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3339197	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3340500	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3341862	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3343309	CHEMBL1166618	Inhibition of PHKG2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	3358730	CHEMBL1175196	Inhibition of PHKG2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	92.0	CHEMBL2349	Homo sapiens	INH	%	92.0
	3359172	CHEMBL1175196	Inhibition of PHKG2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL2349	Homo sapiens	INH	%	100.0
	3443482	CHEMBL1244248	Inhibition of PHKG2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	-3.0	CHEMBL2349	Homo sapiens	INH	%	-3.0
	3443699	CHEMBL1244248	Inhibition of PHKG2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	-8.0	CHEMBL2349	Homo sapiens	INH	%	-8.0
	3444854	CHEMBL1244248	Inhibition of PHKG2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	-9.0	CHEMBL2349	Homo sapiens	INH	%	-9.0
	3445242	CHEMBL1244564	Binding affinity to PHKG2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1.7	CHEMBL2349	Homo sapiens	Kd	nM	1.7
	3445478	CHEMBL1244248	Inhibition of PHKG2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	-3.0	CHEMBL2349	Homo sapiens	INH	%	-3.0
	3445695	CHEMBL1244248	Inhibition of PHKG2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	25.0	CHEMBL2349	Homo sapiens	INH	%	25.0
	3445890	CHEMBL1244248	Inhibition of PHKG2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	20.0	CHEMBL2349	Homo sapiens	INH	%	20.0
	3446080	CHEMBL1244248	Inhibition of PHKG2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	16.0	CHEMBL2349	Homo sapiens	INH	%	16.0
	3448553	CHEMBL1244564	Binding affinity to PHKG2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	3449005	CHEMBL1244564	Binding affinity to PHKG2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	900.0	CHEMBL2349	Homo sapiens	Kd	nM	900.0
	3449305	CHEMBL1244564	Binding affinity to PHKG2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5.9	CHEMBL2349	Homo sapiens	Kd	nM	5.9
	3449784	CHEMBL1244564	Binding affinity to PHKG2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	3450179	CHEMBL1244564	Binding affinity to PHKG2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	3451100	CHEMBL1244564	Binding affinity to PHKG2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	uM	10.0
	3463315	CHEMBL1252617	Inhibition of PHKG2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	11.0	CHEMBL2349	Homo sapiens	INH	%	11.0
	3463859	CHEMBL1252617	Inhibition of PHKG2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	4.0	CHEMBL2349	Homo sapiens	INH	%	4.0
	3464078	CHEMBL1252617	Inhibition of PHKG2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	28.0	CHEMBL2349	Homo sapiens	INH	%	28.0
Not Active	3599529	CHEMBL1291145	Displacement of radiolabeled ZIPtide from PHKG2 at 1 to 3 uM	B	Oc1ccc2c(c1)CCN(CCCCc1ccccc1)CC2O		CHEMBL1289626		Activity			CHEMBL2349	Homo sapiens	Activity		
	5120419	CHEMBL1648669	Inhibition of human PhKgamma2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	109.0	CHEMBL2349	Homo sapiens	INH	%	109.0
	6340985	CHEMBL1827571	Activity of PHKG2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	97.0	CHEMBL2349	Homo sapiens	Activity	%	97.0
	6385553	CHEMBL1837944	Inhibition of human PHKgamma2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	6385554	CHEMBL1837944	Inhibition of human PHKgamma2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	6385555	CHEMBL1837944	Inhibition of human PHKgamma2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	6385556	CHEMBL1837944	Inhibition of human PHKgamma2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	6385557	CHEMBL1837944	Inhibition of human PHKgamma2 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	7567191	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7567650	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7568121	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7568589	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	2400.0	CHEMBL2349	Homo sapiens	Kd	nM	2400.0
	7569164	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7569624	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7570096	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1000.0	CHEMBL2349	Homo sapiens	Kd	nM	1000.0
	7570544	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	5.9	CHEMBL2349	Homo sapiens	Kd	nM	5.9
	7571140	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	1600.0	CHEMBL2349	Homo sapiens	Kd	nM	1600.0
	7571597	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7572094	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7572510	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	13.0	CHEMBL2349	Homo sapiens	Kd	nM	13.0
	7573121	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	260.0	CHEMBL2349	Homo sapiens	Kd	nM	260.0
	7573578	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7573612	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	1700.0	CHEMBL2349	Homo sapiens	Kd	nM	1700.0
	7574081	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1400.0	CHEMBL2349	Homo sapiens	Kd	nM	1400.0
	7574489	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7575099	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	470.0	CHEMBL2349	Homo sapiens	Kd	nM	470.0
	7575589	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7576054	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7576462	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	1600.0	CHEMBL2349	Homo sapiens	Kd	nM	1600.0
	7577090	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7577568	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	140.0	CHEMBL2349	Homo sapiens	Kd	nM	140.0
	7578038	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	760.0	CHEMBL2349	Homo sapiens	Kd	nM	760.0
	7578443	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	7900.0	CHEMBL2349	Homo sapiens	Kd	nM	7900.0
	7578639	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	2600.0	CHEMBL2349	Homo sapiens	Kd	nM	2600.0
	7579013	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7579463	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2900.0	CHEMBL2349	Homo sapiens	Kd	nM	2900.0
	7579937	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7580406	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7580809	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4400.0	CHEMBL2349	Homo sapiens	Kd	nM	4400.0
	7580997	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7581382	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7581827	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7582298	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7582762	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	940.0	CHEMBL2349	Homo sapiens	Kd	nM	940.0
	7583162	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7583343	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7583740	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	460.0	CHEMBL2349	Homo sapiens	Kd	nM	460.0
	7584185	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7584656	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7585118	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7585673	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7586081	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7586527	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2700.0	CHEMBL2349	Homo sapiens	Kd	nM	2700.0
	7586998	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7587634	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7588053	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1.7	CHEMBL2349	Homo sapiens	Kd	nM	1.7
	7588506	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	2100.0	CHEMBL2349	Homo sapiens	Kd	nM	2100.0
	7588986	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7589599	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7590023	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	9000.0	CHEMBL2349	Homo sapiens	Kd	nM	9000.0
	7590522	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7590973	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7591572	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7591994	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7592024	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7592497	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7592950	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1300.0	CHEMBL2349	Homo sapiens	Kd	nM	1300.0
	7593539	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7594004	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7594477	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7594929	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7595509	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7595983	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7596454	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7596901	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	0.14	CHEMBL2349	Homo sapiens	Kd	nM	0.14
	7597037	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7597490	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7597963	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7598433	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2349	Homo sapiens	Kd	nM	10000.0
	7598875	CHEMBL1908494	Binding constant for PHKG2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	100.0	CHEMBL2349	Homo sapiens	Kd	nM	100.0
	7961103	CHEMBL1931533	Inhibition of PHKgamma2	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2349	Homo sapiens	IC50	uM	30.0
	7961104	CHEMBL1931533	Inhibition of PHKgamma2	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2349	Homo sapiens	IC50	uM	30.0
	7992211	CHEMBL1937331	Inhibition of PHKG2 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	8047157	CHEMBL1959382	Inhibition of PHKG2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	8061276	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.02	CHEMBL2349	Homo sapiens	Inhibition	%	0.02
	8061453	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-6.49	CHEMBL2349	Homo sapiens	Inhibition	%	-6.49
	8061784	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.68	CHEMBL2349	Homo sapiens	Inhibition	%	2.68
	8061975	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.23	CHEMBL2349	Homo sapiens	Inhibition	%	2.23
	8062199	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.8	CHEMBL2349	Homo sapiens	Inhibition	%	2.8
	8062315	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.05	CHEMBL2349	Homo sapiens	Inhibition	%	4.05
	8062701	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.95	CHEMBL2349	Homo sapiens	Inhibition	%	5.95
	8062799	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.15	CHEMBL2349	Homo sapiens	Inhibition	%	-0.15
	8063023	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.07	CHEMBL2349	Homo sapiens	Inhibition	%	1.07
	8063155	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-1.08	CHEMBL2349	Homo sapiens	Inhibition	%	-1.08
	8063322	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	2.13	CHEMBL2349	Homo sapiens	Inhibition	%	2.13
	8063546	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	5.41	CHEMBL2349	Homo sapiens	Inhibition	%	5.41
	8063654	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.32	CHEMBL2349	Homo sapiens	Inhibition	%	3.32
	8064060	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.75	CHEMBL2349	Homo sapiens	Inhibition	%	1.75
	8064175	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.59	CHEMBL2349	Homo sapiens	Inhibition	%	1.59
	8064609	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.09	CHEMBL2349	Homo sapiens	Inhibition	%	-1.09
	8064747	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.22	CHEMBL2349	Homo sapiens	Inhibition	%	0.22
	8065137	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.93	CHEMBL2349	Homo sapiens	Inhibition	%	0.93
	8065253	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.73	CHEMBL2349	Homo sapiens	Inhibition	%	3.73
	8065477	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.62	CHEMBL2349	Homo sapiens	Inhibition	%	3.62
	8065652	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.4	CHEMBL2349	Homo sapiens	Inhibition	%	0.4
	8065767	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.21	CHEMBL2349	Homo sapiens	Inhibition	%	1.21
	8065991	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.74	CHEMBL2349	Homo sapiens	Inhibition	%	-0.74
	8066201	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.2	CHEMBL2349	Homo sapiens	Inhibition	%	-0.2
	8066337	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.01	CHEMBL2349	Homo sapiens	Inhibition	%	2.01
	8066561	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.69	CHEMBL2349	Homo sapiens	Inhibition	%	2.69
	8066727	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	5.44	CHEMBL2349	Homo sapiens	Inhibition	%	5.44
	8067075	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.45	CHEMBL2349	Homo sapiens	Inhibition	%	2.45
	8067250	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.73	CHEMBL2349	Homo sapiens	Inhibition	%	2.73
	8067595	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.28	CHEMBL2349	Homo sapiens	Inhibition	%	0.28
	8067805	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-2.03	CHEMBL2349	Homo sapiens	Inhibition	%	-2.03
	8068164	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	15.57	CHEMBL2349	Homo sapiens	Inhibition	%	15.57
	8068328	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.85	CHEMBL2349	Homo sapiens	Inhibition	%	1.85
	8068677	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.0	CHEMBL2349	Homo sapiens	Inhibition	%	1.0
	8068851	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.31	CHEMBL2349	Homo sapiens	Inhibition	%	0.31
	8069200	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.7	CHEMBL2349	Homo sapiens	Inhibition	%	-0.7
	8069495	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	5.13	CHEMBL2349	Homo sapiens	Inhibition	%	5.13
	8069656	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	6.04	CHEMBL2349	Homo sapiens	Inhibition	%	6.04
	8069880	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.58	CHEMBL2349	Homo sapiens	Inhibition	%	2.58
	8070006	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.36	CHEMBL2349	Homo sapiens	Inhibition	%	1.36
	8070178	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.08	CHEMBL2349	Homo sapiens	Inhibition	%	4.08
	8070402	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.1	CHEMBL2349	Homo sapiens	Inhibition	%	1.1
	8070527	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.69	CHEMBL2349	Homo sapiens	Inhibition	%	-0.69
	8070825	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	25.72	CHEMBL2349	Homo sapiens	Inhibition	%	25.72
	8071206	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	5.19	CHEMBL2349	Homo sapiens	Inhibition	%	5.19
	8071332	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.65	CHEMBL2349	Homo sapiens	Inhibition	%	-0.65
	8071729	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.24	CHEMBL2349	Homo sapiens	Inhibition	%	4.24
	8071854	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.76	CHEMBL2349	Homo sapiens	Inhibition	%	-0.76
	8072078	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.83	CHEMBL2349	Homo sapiens	Inhibition	%	-0.83
	8072168	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.89	CHEMBL2349	Homo sapiens	Inhibition	%	-0.89
	8072549	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.43	CHEMBL2349	Homo sapiens	Inhibition	%	4.43
	8072674	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.32	CHEMBL2349	Homo sapiens	Inhibition	%	-0.32
	8072898	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.54	CHEMBL2349	Homo sapiens	Inhibition	%	-1.54
	8073065	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.34	CHEMBL2349	Homo sapiens	Inhibition	%	1.34
	8073414	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-1.17	CHEMBL2349	Homo sapiens	Inhibition	%	-1.17
	8073533	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.11	CHEMBL2349	Homo sapiens	Inhibition	%	1.11
	8073757	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.07	CHEMBL2349	Homo sapiens	Inhibition	%	0.07
	8073766	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-1.83	CHEMBL2349	Homo sapiens	Inhibition	%	-1.83
	8073990	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-2.3	CHEMBL2349	Homo sapiens	Inhibition	%	-2.3
	8074142	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	6.25	CHEMBL2349	Homo sapiens	Inhibition	%	6.25
	8074496	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.32	CHEMBL2349	Homo sapiens	Inhibition	%	-0.32
	8074653	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.61	CHEMBL2349	Homo sapiens	Inhibition	%	2.61
	8075004	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.68	CHEMBL2349	Homo sapiens	Inhibition	%	-1.68
	8075339	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.42	CHEMBL2349	Homo sapiens	Inhibition	%	-0.42
	8075576	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.9	CHEMBL2349	Homo sapiens	Inhibition	%	-1.9
	8075717	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	4.58	CHEMBL2349	Homo sapiens	Inhibition	%	4.58
	8076083	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.44	CHEMBL2349	Homo sapiens	Inhibition	%	-1.44
	8076231	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.83	CHEMBL2349	Homo sapiens	Inhibition	%	0.83
	8076455	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.37	CHEMBL2349	Homo sapiens	Inhibition	%	1.37
	8076589	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.96	CHEMBL2349	Homo sapiens	Inhibition	%	0.96
	8076915	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.63	CHEMBL2349	Homo sapiens	Inhibition	%	-2.63
	8077162	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-3.09	CHEMBL2349	Homo sapiens	Inhibition	%	-3.09
	8077290	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	5.29	CHEMBL2349	Homo sapiens	Inhibition	%	5.29
	8077514	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.78	CHEMBL2349	Homo sapiens	Inhibition	%	2.78
	8077665	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.1	CHEMBL2349	Homo sapiens	Inhibition	%	0.1
	8078032	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.33	CHEMBL2349	Homo sapiens	Inhibition	%	0.33
	8078171	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-5.86	CHEMBL2349	Homo sapiens	Inhibition	%	-5.86
	8078497	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.29	CHEMBL2349	Homo sapiens	Inhibition	%	0.29
	8078747	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.93	CHEMBL2349	Homo sapiens	Inhibition	%	-0.93
	8079087	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.43	CHEMBL2349	Homo sapiens	Inhibition	%	4.43
	8079245	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-2.13	CHEMBL2349	Homo sapiens	Inhibition	%	-2.13
	8079611	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.22	CHEMBL2349	Homo sapiens	Inhibition	%	2.22
	8079750	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-3.66	CHEMBL2349	Homo sapiens	Inhibition	%	-3.66
	8079974	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	25.67	CHEMBL2349	Homo sapiens	Inhibition	%	25.67
	8080079	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-2.23	CHEMBL2349	Homo sapiens	Inhibition	%	-2.23
	8080331	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.63	CHEMBL2349	Homo sapiens	Inhibition	%	-1.63
	8080670	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.92	CHEMBL2349	Homo sapiens	Inhibition	%	1.92
	8080834	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.44	CHEMBL2349	Homo sapiens	Inhibition	%	-1.44
	8081058	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-6.47	CHEMBL2349	Homo sapiens	Inhibition	%	-6.47
	8081193	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.5	CHEMBL2349	Homo sapiens	Inhibition	%	0.5
	8081561	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	71.69	CHEMBL2349	Homo sapiens	Inhibition	%	71.69
	8081664	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.35	CHEMBL2349	Homo sapiens	Inhibition	%	1.35
	8081888	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-1.03	CHEMBL2349	Homo sapiens	Inhibition	%	-1.03
	8081916	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	16.43	CHEMBL2349	Homo sapiens	Inhibition	%	16.43
	8082140	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-4.48	CHEMBL2349	Homo sapiens	Inhibition	%	-4.48
	8082253	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.81	CHEMBL2349	Homo sapiens	Inhibition	%	2.81
	8082650	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-6.27	CHEMBL2349	Homo sapiens	Inhibition	%	-6.27
	8082773	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.61	CHEMBL2349	Homo sapiens	Inhibition	%	3.61
	8082997	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.0	CHEMBL2349	Homo sapiens	Inhibition	%	2.0
	8083153	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.91	CHEMBL2349	Homo sapiens	Inhibition	%	3.91
	8083476	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.36	CHEMBL2349	Homo sapiens	Inhibition	%	2.36
	8083730	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-2.24	CHEMBL2349	Homo sapiens	Inhibition	%	-2.24
	8083840	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.82	CHEMBL2349	Homo sapiens	Inhibition	%	2.82
	8084064	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.94	CHEMBL2349	Homo sapiens	Inhibition	%	2.94
	8084249	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	3.72	CHEMBL2349	Homo sapiens	Inhibition	%	3.72
	8084591	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.31	CHEMBL2349	Homo sapiens	Inhibition	%	3.31
	8084752	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	10.0	CHEMBL2349	Homo sapiens	Inhibition	%	10.0
	8085074	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.09	CHEMBL2349	Homo sapiens	Inhibition	%	-0.09
	8085330	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-7.11	CHEMBL2349	Homo sapiens	Inhibition	%	-7.11
	8085662	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.49	CHEMBL2349	Homo sapiens	Inhibition	%	3.49
	8085851	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	14.14	CHEMBL2349	Homo sapiens	Inhibition	%	14.14
	8086190	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.97	CHEMBL2349	Homo sapiens	Inhibition	%	1.97
	8086352	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	4.67	CHEMBL2349	Homo sapiens	Inhibition	%	4.67
	8086576	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	9.01	CHEMBL2349	Homo sapiens	Inhibition	%	9.01
	8086675	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.66	CHEMBL2349	Homo sapiens	Inhibition	%	2.66
	8086886	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.13	CHEMBL2349	Homo sapiens	Inhibition	%	4.13
	8087110	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.55	CHEMBL2349	Homo sapiens	Inhibition	%	4.55
	8087268	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.68	CHEMBL2349	Homo sapiens	Inhibition	%	2.68
	8087606	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.65	CHEMBL2349	Homo sapiens	Inhibition	%	5.65
	8087744	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.85	CHEMBL2349	Homo sapiens	Inhibition	%	2.85
	8088110	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.28	CHEMBL2349	Homo sapiens	Inhibition	%	7.28
	8088258	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.4	CHEMBL2349	Homo sapiens	Inhibition	%	1.4
	8088482	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.02	CHEMBL2349	Homo sapiens	Inhibition	%	0.02
	8088610	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.55	CHEMBL2349	Homo sapiens	Inhibition	%	6.55
	8088927	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.96	CHEMBL2349	Homo sapiens	Inhibition	%	0.96
	8089055	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.41	CHEMBL2349	Homo sapiens	Inhibition	%	-0.41
	8089279	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.31	CHEMBL2349	Homo sapiens	Inhibition	%	0.31
	8089427	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.74	CHEMBL2349	Homo sapiens	Inhibition	%	1.74
	8089771	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.67	CHEMBL2349	Homo sapiens	Inhibition	%	1.67
	8089951	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.54	CHEMBL2349	Homo sapiens	Inhibition	%	0.54
	8090340	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.63	CHEMBL2349	Homo sapiens	Inhibition	%	5.63
	8090507	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.22	CHEMBL2349	Homo sapiens	Inhibition	%	3.22
	8090870	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.6	CHEMBL2349	Homo sapiens	Inhibition	%	3.6
	8091075	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.78	CHEMBL2349	Homo sapiens	Inhibition	%	4.78
	8091436	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	7.18	CHEMBL2349	Homo sapiens	Inhibition	%	7.18
	8091591	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.43	CHEMBL2349	Homo sapiens	Inhibition	%	2.43
	8091931	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.8	CHEMBL2349	Homo sapiens	Inhibition	%	5.8
	8092068	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.69	CHEMBL2349	Homo sapiens	Inhibition	%	1.69
	8092292	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.14	CHEMBL2349	Homo sapiens	Inhibition	%	1.14
	8092443	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.77	CHEMBL2349	Homo sapiens	Inhibition	%	3.77
	8092815	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-1.25	CHEMBL2349	Homo sapiens	Inhibition	%	-1.25
	8092944	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.6	CHEMBL2349	Homo sapiens	Inhibition	%	6.6
	8093256	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.88	CHEMBL2349	Homo sapiens	Inhibition	%	2.88
	8093620	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.07	CHEMBL2349	Homo sapiens	Inhibition	%	-2.07
	8093759	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	8.45	CHEMBL2349	Homo sapiens	Inhibition	%	8.45
	8094103	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.7	CHEMBL2349	Homo sapiens	Inhibition	%	0.7
	8094283	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.33	CHEMBL2349	Homo sapiens	Inhibition	%	1.33
	8094507	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.22	CHEMBL2349	Homo sapiens	Inhibition	%	1.22
	8094682	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	19.08	CHEMBL2349	Homo sapiens	Inhibition	%	19.08
	8094838	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.98	CHEMBL2349	Homo sapiens	Inhibition	%	3.98
	8095062	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.94	CHEMBL2349	Homo sapiens	Inhibition	%	3.94
	8095202	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	2.53	CHEMBL2349	Homo sapiens	Inhibition	%	2.53
	8095405	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	4.2	CHEMBL2349	Homo sapiens	Inhibition	%	4.2
	8095770	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	16.41	CHEMBL2349	Homo sapiens	Inhibition	%	16.41
	8095918	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.67	CHEMBL2349	Homo sapiens	Inhibition	%	2.67
	8096142	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.41	CHEMBL2349	Homo sapiens	Inhibition	%	2.41
	8096259	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	8.37	CHEMBL2349	Homo sapiens	Inhibition	%	8.37
	8096622	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	2.31	CHEMBL2349	Homo sapiens	Inhibition	%	2.31
	8096778	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.76	CHEMBL2349	Homo sapiens	Inhibition	%	4.76
	8097149	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-2.01	CHEMBL2349	Homo sapiens	Inhibition	%	-2.01
	8097456	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	-0.79	CHEMBL2349	Homo sapiens	Inhibition	%	-0.79
	8097830	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.54	CHEMBL2349	Homo sapiens	Inhibition	%	-2.54
	8097963	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.36	CHEMBL2349	Homo sapiens	Inhibition	%	1.36
	8098187	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	4.11	CHEMBL2349	Homo sapiens	Inhibition	%	4.11
	8098307	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.62	CHEMBL2349	Homo sapiens	Inhibition	%	1.62
	8098711	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.07	CHEMBL2349	Homo sapiens	Inhibition	%	1.07
	8098896	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	64.69	CHEMBL2349	Homo sapiens	Inhibition	%	64.69
	8099264	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.59	CHEMBL2349	Homo sapiens	Inhibition	%	3.59
	8099406	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.43	CHEMBL2349	Homo sapiens	Inhibition	%	4.43
	8099600	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.29	CHEMBL2349	Homo sapiens	Inhibition	%	1.29
	8099824	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.44	CHEMBL2349	Homo sapiens	Inhibition	%	0.44
	8099971	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.73	CHEMBL2349	Homo sapiens	Inhibition	%	5.73
	8100341	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.94	CHEMBL2349	Homo sapiens	Inhibition	%	1.94
	8100457	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.18	CHEMBL2349	Homo sapiens	Inhibition	%	7.18
	8100681	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.1	CHEMBL2349	Homo sapiens	Inhibition	%	4.1
	8100821	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.04	CHEMBL2349	Homo sapiens	Inhibition	%	-0.04
	8100981	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.73	CHEMBL2349	Homo sapiens	Inhibition	%	5.73
	8101205	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.45	CHEMBL2349	Homo sapiens	Inhibition	%	5.45
	8101347	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.9	CHEMBL2349	Homo sapiens	Inhibition	%	-2.9
	8101532	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	6.0	CHEMBL2349	Homo sapiens	Inhibition	%	6.0
	8101756	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	5.0	CHEMBL2349	Homo sapiens	Inhibition	%	5.0
	8101785	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.45	CHEMBL2349	Homo sapiens	Inhibition	%	3.45
	8102009	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.52	CHEMBL2349	Homo sapiens	Inhibition	%	1.52
	8102164	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-5.45	CHEMBL2349	Homo sapiens	Inhibition	%	-5.45
	8102519	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.23	CHEMBL2349	Homo sapiens	Inhibition	%	2.23
	8102639	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.45	CHEMBL2349	Homo sapiens	Inhibition	%	0.45
	8102863	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.37	CHEMBL2349	Homo sapiens	Inhibition	%	1.37
	8103041	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	2.25	CHEMBL2349	Homo sapiens	Inhibition	%	2.25
	8103237	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.76	CHEMBL2349	Homo sapiens	Inhibition	%	2.76
	8103599	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.29	CHEMBL2349	Homo sapiens	Inhibition	%	1.29
	8103749	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	4.18	CHEMBL2349	Homo sapiens	Inhibition	%	4.18
	8104158	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.21	CHEMBL2349	Homo sapiens	Inhibition	%	1.21
	8104306	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.98	CHEMBL2349	Homo sapiens	Inhibition	%	5.98
	8104676	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	4.44	CHEMBL2349	Homo sapiens	Inhibition	%	4.44
	8105014	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.74	CHEMBL2349	Homo sapiens	Inhibition	%	4.74
	8105154	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-2.35	CHEMBL2349	Homo sapiens	Inhibition	%	-2.35
	8105544	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.55	CHEMBL2349	Homo sapiens	Inhibition	%	5.55
	8105682	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.15	CHEMBL2349	Homo sapiens	Inhibition	%	-2.15
	8105962	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.82	CHEMBL2349	Homo sapiens	Inhibition	%	3.82
	8106351	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.52	CHEMBL2349	Homo sapiens	Inhibition	%	2.52
	8106507	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.62	CHEMBL2349	Homo sapiens	Inhibition	%	-1.62
	8106860	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.3	CHEMBL2349	Homo sapiens	Inhibition	%	2.3
	8107205	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.3	CHEMBL2349	Homo sapiens	Inhibition	%	1.3
	8107377	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.5	CHEMBL2349	Homo sapiens	Inhibition	%	2.5
	8107578	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	5.27	CHEMBL2349	Homo sapiens	Inhibition	%	5.27
	8107802	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.92	CHEMBL2349	Homo sapiens	Inhibition	%	2.92
	8107937	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.54	CHEMBL2349	Homo sapiens	Inhibition	%	0.54
	8108095	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.8	CHEMBL2349	Homo sapiens	Inhibition	%	5.8
	8108319	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.01	CHEMBL2349	Homo sapiens	Inhibition	%	5.01
	8108494	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.57	CHEMBL2349	Homo sapiens	Inhibition	%	1.57
	8108641	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.59	CHEMBL2349	Homo sapiens	Inhibition	%	8.59
	8108865	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	9.94	CHEMBL2349	Homo sapiens	Inhibition	%	9.94
	8109007	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.75	CHEMBL2349	Homo sapiens	Inhibition	%	1.75
	8109345	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.29	CHEMBL2349	Homo sapiens	Inhibition	%	5.29
	8109475	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-2.67	CHEMBL2349	Homo sapiens	Inhibition	%	-2.67
	8109699	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-2.36	CHEMBL2349	Homo sapiens	Inhibition	%	-2.36
	8109870	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	4.86	CHEMBL2349	Homo sapiens	Inhibition	%	4.86
	8110002	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.54	CHEMBL2349	Homo sapiens	Inhibition	%	4.54
	8110226	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	5.45	CHEMBL2349	Homo sapiens	Inhibition	%	5.45
	8110281	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.55	CHEMBL2349	Homo sapiens	Inhibition	%	1.55
	8110505	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.98	CHEMBL2349	Homo sapiens	Inhibition	%	3.98
	8110671	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.17	CHEMBL2349	Homo sapiens	Inhibition	%	0.17
	8110829	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.7	CHEMBL2349	Homo sapiens	Inhibition	%	-1.7
	8111053	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	4.75	CHEMBL2349	Homo sapiens	Inhibition	%	4.75
	8111176	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.07	CHEMBL2349	Homo sapiens	Inhibition	%	3.07
	8111527	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.45	CHEMBL2349	Homo sapiens	Inhibition	%	1.45
	8111693	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.01	CHEMBL2349	Homo sapiens	Inhibition	%	3.01
	8112122	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.71	CHEMBL2349	Homo sapiens	Inhibition	%	3.71
	8112259	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.83	CHEMBL2349	Homo sapiens	Inhibition	%	0.83
	8112651	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.23	CHEMBL2349	Homo sapiens	Inhibition	%	6.23
	8112823	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.65	CHEMBL2349	Homo sapiens	Inhibition	%	0.65
	8113199	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.52	CHEMBL2349	Homo sapiens	Inhibition	%	3.52
	8113335	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.77	CHEMBL2349	Homo sapiens	Inhibition	%	-0.77
	8113559	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-1.65	CHEMBL2349	Homo sapiens	Inhibition	%	-1.65
	8113683	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	5.11	CHEMBL2349	Homo sapiens	Inhibition	%	5.11
	8114023	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-4.51	CHEMBL2349	Homo sapiens	Inhibition	%	-4.51
	8114199	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	5.95	CHEMBL2349	Homo sapiens	Inhibition	%	5.95
	8114555	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.96	CHEMBL2349	Homo sapiens	Inhibition	%	4.96
	8114831	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.55	CHEMBL2349	Homo sapiens	Inhibition	%	1.55
	8114997	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.69	CHEMBL2349	Homo sapiens	Inhibition	%	2.69
	8115386	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.59	CHEMBL2349	Homo sapiens	Inhibition	%	0.59
	8115506	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.57	CHEMBL2349	Homo sapiens	Inhibition	%	3.57
	8115730	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.04	CHEMBL2349	Homo sapiens	Inhibition	%	3.04
	8115863	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.65	CHEMBL2349	Homo sapiens	Inhibition	%	1.65
	8116022	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.52	CHEMBL2349	Homo sapiens	Inhibition	%	0.52
	8116246	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	3.4	CHEMBL2349	Homo sapiens	Inhibition	%	3.4
	8116449	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	4.06	CHEMBL2349	Homo sapiens	Inhibition	%	4.06
	8116583	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.29	CHEMBL2349	Homo sapiens	Inhibition	%	0.29
	8116807	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.03	CHEMBL2349	Homo sapiens	Inhibition	%	0.03
	8116979	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	6.66	CHEMBL2349	Homo sapiens	Inhibition	%	6.66
	8117150	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.15	CHEMBL2349	Homo sapiens	Inhibition	%	0.15
	8117374	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.33	CHEMBL2349	Homo sapiens	Inhibition	%	0.33
	8117532	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	4.33	CHEMBL2349	Homo sapiens	Inhibition	%	4.33
	8117886	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-2.44	CHEMBL2349	Homo sapiens	Inhibition	%	-2.44
	8118024	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.85	CHEMBL2349	Homo sapiens	Inhibition	%	4.85
	8118364	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.72	CHEMBL2349	Homo sapiens	Inhibition	%	3.72
	8118536	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.97	CHEMBL2349	Homo sapiens	Inhibition	%	4.97
	8118760	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.51	CHEMBL2349	Homo sapiens	Inhibition	%	5.51
	8118896	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.36	CHEMBL2349	Homo sapiens	Inhibition	%	5.36
	8119167	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	4.74	CHEMBL2349	Homo sapiens	Inhibition	%	4.74
	8119326	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-1.12	CHEMBL2349	Homo sapiens	Inhibition	%	-1.12
	8119550	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.34	CHEMBL2349	Homo sapiens	Inhibition	%	3.34
	8119717	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	6.86	CHEMBL2349	Homo sapiens	Inhibition	%	6.86
	8120060	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.64	CHEMBL2349	Homo sapiens	Inhibition	%	3.64
	8120199	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.58	CHEMBL2349	Homo sapiens	Inhibition	%	1.58
	8120583	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.83	CHEMBL2349	Homo sapiens	Inhibition	%	-0.83
	8120784	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.58	CHEMBL2349	Homo sapiens	Inhibition	%	3.58
	8121136	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.32	CHEMBL2349	Homo sapiens	Inhibition	%	0.32
	8121308	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	3.27	CHEMBL2349	Homo sapiens	Inhibition	%	3.27
	8121699	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.92	CHEMBL2349	Homo sapiens	Inhibition	%	-0.92
	8121862	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.32	CHEMBL2349	Homo sapiens	Inhibition	%	4.32
	8122207	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-2.51	CHEMBL2349	Homo sapiens	Inhibition	%	-2.51
	8122345	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.7	CHEMBL2349	Homo sapiens	Inhibition	%	4.7
	8122569	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	7.45	CHEMBL2349	Homo sapiens	Inhibition	%	7.45
	8122689	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.17	CHEMBL2349	Homo sapiens	Inhibition	%	5.17
	8123080	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	5.22	CHEMBL2349	Homo sapiens	Inhibition	%	5.22
	8123222	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	5.36	CHEMBL2349	Homo sapiens	Inhibition	%	5.36
	8123500	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	8.82	CHEMBL2349	Homo sapiens	Inhibition	%	8.82
	8123874	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.0	CHEMBL2349	Homo sapiens	Inhibition	%	2.0
	8124041	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.83	CHEMBL2349	Homo sapiens	Inhibition	%	1.83
	8124384	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.4	CHEMBL2349	Homo sapiens	Inhibition	%	4.4
	8124523	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.14	CHEMBL2349	Homo sapiens	Inhibition	%	1.14
	8124747	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	3.23	CHEMBL2349	Homo sapiens	Inhibition	%	3.23
	8124912	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.47	CHEMBL2349	Homo sapiens	Inhibition	%	-1.47
	8125113	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.05	CHEMBL2349	Homo sapiens	Inhibition	%	5.05
	8125467	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.23	CHEMBL2349	Homo sapiens	Inhibition	%	-1.23
	8125635	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.45	CHEMBL2349	Homo sapiens	Inhibition	%	2.45
	8125859	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	3.98	CHEMBL2349	Homo sapiens	Inhibition	%	3.98
	8126023	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.86	CHEMBL2349	Homo sapiens	Inhibition	%	-0.86
	8126187	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.93	CHEMBL2349	Homo sapiens	Inhibition	%	5.93
	8126526	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-5.1	CHEMBL2349	Homo sapiens	Inhibition	%	-5.1
	8126886	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	19.81	CHEMBL2349	Homo sapiens	Inhibition	%	19.81
	8127008	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	5.51	CHEMBL2349	Homo sapiens	Inhibition	%	5.51
	8127232	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	6.26	CHEMBL2349	Homo sapiens	Inhibition	%	6.26
	8127399	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	6.86	CHEMBL2349	Homo sapiens	Inhibition	%	6.86
	8127541	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	6.56	CHEMBL2349	Homo sapiens	Inhibition	%	6.56
	8127765	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	6.43	CHEMBL2349	Homo sapiens	Inhibition	%	6.43
	8127829	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.66	CHEMBL2349	Homo sapiens	Inhibition	%	2.66
	8128053	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	-0.4	CHEMBL2349	Homo sapiens	Inhibition	%	-0.4
	8128205	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.55	CHEMBL2349	Homo sapiens	Inhibition	%	2.55
	8128372	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	6.48	CHEMBL2349	Homo sapiens	Inhibition	%	6.48
	8128596	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	1.88	CHEMBL2349	Homo sapiens	Inhibition	%	1.88
	8128715	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	18.81	CHEMBL2349	Homo sapiens	Inhibition	%	18.81
	8129076	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.81	CHEMBL2349	Homo sapiens	Inhibition	%	2.81
	8129247	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.99	CHEMBL2349	Homo sapiens	Inhibition	%	-1.99
	8129436	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	5.44	CHEMBL2349	Homo sapiens	Inhibition	%	5.44
	8129660	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.03	CHEMBL2349	Homo sapiens	Inhibition	%	2.03
	8129799	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.9	CHEMBL2349	Homo sapiens	Inhibition	%	-1.9
	8130184	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	4.36	CHEMBL2349	Homo sapiens	Inhibition	%	4.36
	8130356	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.05	CHEMBL2349	Homo sapiens	Inhibition	%	-1.05
	8130516	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	5.93	CHEMBL2349	Homo sapiens	Inhibition	%	5.93
	8130740	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	15.29	CHEMBL2349	Homo sapiens	Inhibition	%	15.29
	8130856	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.27	CHEMBL2349	Homo sapiens	Inhibition	%	4.27
	8131219	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.53	CHEMBL2349	Homo sapiens	Inhibition	%	4.53
	8131563	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.4	CHEMBL2349	Homo sapiens	Inhibition	%	5.4
	8131730	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	8.13	CHEMBL2349	Homo sapiens	Inhibition	%	8.13
	8132095	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.64	CHEMBL2349	Homo sapiens	Inhibition	%	4.64
	8132381	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.64	CHEMBL2349	Homo sapiens	Inhibition	%	3.64
	8132528	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	0.54	CHEMBL2349	Homo sapiens	Inhibition	%	0.54
	8132920	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	5.64	CHEMBL2349	Homo sapiens	Inhibition	%	5.64
	8133041	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.58	CHEMBL2349	Homo sapiens	Inhibition	%	2.58
	8133265	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.28	CHEMBL2349	Homo sapiens	Inhibition	%	2.28
	8133403	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	3.86	CHEMBL2349	Homo sapiens	Inhibition	%	3.86
	8133575	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.19	CHEMBL2349	Homo sapiens	Inhibition	%	-1.19
	8133799	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.2	CHEMBL2349	Homo sapiens	Inhibition	%	-2.2
	8133979	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.05	CHEMBL2349	Homo sapiens	Inhibition	%	3.05
	8134127	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.54	CHEMBL2349	Homo sapiens	Inhibition	%	-1.54
	8134351	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-2.23	CHEMBL2349	Homo sapiens	Inhibition	%	-2.23
	8134511	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.37	CHEMBL2349	Homo sapiens	Inhibition	%	3.37
	8134695	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-3.81	CHEMBL2349	Homo sapiens	Inhibition	%	-3.81
	8135079	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.5	CHEMBL2349	Homo sapiens	Inhibition	%	1.5
	8135194	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	4.0	CHEMBL2349	Homo sapiens	Inhibition	%	4.0
	8135418	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.4	CHEMBL2349	Homo sapiens	Inhibition	%	5.4
	8135559	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	5.85	CHEMBL2349	Homo sapiens	Inhibition	%	5.85
	8135904	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.05	CHEMBL2349	Homo sapiens	Inhibition	%	5.05
	8136072	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.6	CHEMBL2349	Homo sapiens	Inhibition	%	3.6
	8136440	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	7.66	CHEMBL2349	Homo sapiens	Inhibition	%	7.66
	8136730	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.16	CHEMBL2349	Homo sapiens	Inhibition	%	-0.16
	8136865	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.86	CHEMBL2349	Homo sapiens	Inhibition	%	2.86
	8137089	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	-0.26	CHEMBL2349	Homo sapiens	Inhibition	%	-0.26
	8137252	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.56	CHEMBL2349	Homo sapiens	Inhibition	%	2.56
	8137596	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.11	CHEMBL2349	Homo sapiens	Inhibition	%	2.11
	8137744	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.27	CHEMBL2349	Homo sapiens	Inhibition	%	4.27
	8138134	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.57	CHEMBL2349	Homo sapiens	Inhibition	%	-2.57
	8138313	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.6	CHEMBL2349	Homo sapiens	Inhibition	%	2.6
	8138685	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-5.49	CHEMBL2349	Homo sapiens	Inhibition	%	-5.49
	8138843	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.24	CHEMBL2349	Homo sapiens	Inhibition	%	3.24
	8139028	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	5.2	CHEMBL2349	Homo sapiens	Inhibition	%	5.2
	8139252	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.05	CHEMBL2349	Homo sapiens	Inhibition	%	4.05
	8139411	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	5.59	CHEMBL2349	Homo sapiens	Inhibition	%	5.59
	8139749	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	5.06	CHEMBL2349	Homo sapiens	Inhibition	%	5.06
	8139890	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	7.01	CHEMBL2349	Homo sapiens	Inhibition	%	7.01
	8140114	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.77	CHEMBL2349	Homo sapiens	Inhibition	%	6.77
	8140237	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	5.58	CHEMBL2349	Homo sapiens	Inhibition	%	5.58
	8140396	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.4	CHEMBL2349	Homo sapiens	Inhibition	%	2.4
	8140620	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.8	CHEMBL2349	Homo sapiens	Inhibition	%	3.8
	8140763	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.8	CHEMBL2349	Homo sapiens	Inhibition	%	5.8
	8141065	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.23	CHEMBL2349	Homo sapiens	Inhibition	%	3.23
	8141419	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.75	CHEMBL2349	Homo sapiens	Inhibition	%	0.75
	8141579	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	7.69	CHEMBL2349	Homo sapiens	Inhibition	%	7.69
	8141922	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.8	CHEMBL2349	Homo sapiens	Inhibition	%	0.8
	8142083	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.91	CHEMBL2349	Homo sapiens	Inhibition	%	0.91
	8142475	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.2	CHEMBL2349	Homo sapiens	Inhibition	%	-1.2
	8142651	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.29	CHEMBL2349	Homo sapiens	Inhibition	%	2.29
	8143024	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-6.57	CHEMBL2349	Homo sapiens	Inhibition	%	-6.57
	8143179	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.68	CHEMBL2349	Homo sapiens	Inhibition	%	3.68
	8143590	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.75	CHEMBL2349	Homo sapiens	Inhibition	%	4.75
	8143749	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.1	CHEMBL2349	Homo sapiens	Inhibition	%	4.1
	8144087	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	5.03	CHEMBL2349	Homo sapiens	Inhibition	%	5.03
	8144450	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.19	CHEMBL2349	Homo sapiens	Inhibition	%	3.19
	8144580	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.12	CHEMBL2349	Homo sapiens	Inhibition	%	4.12
	8144957	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.18	CHEMBL2349	Homo sapiens	Inhibition	%	3.18
	8145094	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.91	CHEMBL2349	Homo sapiens	Inhibition	%	7.91
	8145318	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.71	CHEMBL2349	Homo sapiens	Inhibition	%	7.71
	8145407	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.08	CHEMBL2349	Homo sapiens	Inhibition	%	0.08
	8145755	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.31	CHEMBL2349	Homo sapiens	Inhibition	%	-0.31
	8145916	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.8	CHEMBL2349	Homo sapiens	Inhibition	%	2.8
	8146140	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	6.5	CHEMBL2349	Homo sapiens	Inhibition	%	6.5
	8146260	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.59	CHEMBL2349	Homo sapiens	Inhibition	%	1.59
	8146420	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.83	CHEMBL2349	Homo sapiens	Inhibition	%	0.83
	8146644	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.5	CHEMBL2349	Homo sapiens	Inhibition	%	-0.5
	8146811	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	10.83	CHEMBL2349	Homo sapiens	Inhibition	%	10.83
	8146980	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.73	CHEMBL2349	Homo sapiens	Inhibition	%	1.73
	8147204	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.52	CHEMBL2349	Homo sapiens	Inhibition	%	2.52
	8147346	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.99	CHEMBL2349	Homo sapiens	Inhibition	%	2.99
	8147499	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.32	CHEMBL2349	Homo sapiens	Inhibition	%	4.32
	8147723	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.42	CHEMBL2349	Homo sapiens	Inhibition	%	4.42
	8147910	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	4.41	CHEMBL2349	Homo sapiens	Inhibition	%	4.41
	8148068	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.82	CHEMBL2349	Homo sapiens	Inhibition	%	4.82
	8148292	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.62	CHEMBL2349	Homo sapiens	Inhibition	%	6.62
	8148406	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.55	CHEMBL2349	Homo sapiens	Inhibition	%	4.55
	8148769	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.37	CHEMBL2349	Homo sapiens	Inhibition	%	3.37
	8148907	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.89	CHEMBL2349	Homo sapiens	Inhibition	%	5.89
	8149131	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	5.72	CHEMBL2349	Homo sapiens	Inhibition	%	5.72
	8149290	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.91	CHEMBL2349	Homo sapiens	Inhibition	%	1.91
	8149648	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	5.01	CHEMBL2349	Homo sapiens	Inhibition	%	5.01
	8149746	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.46	CHEMBL2349	Homo sapiens	Inhibition	%	4.46
	8149970	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.16	CHEMBL2349	Homo sapiens	Inhibition	%	1.16
	8150095	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.46	CHEMBL2349	Homo sapiens	Inhibition	%	0.46
	8150479	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.39	CHEMBL2349	Homo sapiens	Inhibition	%	2.39
	8150599	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.05	CHEMBL2349	Homo sapiens	Inhibition	%	0.05
	8150988	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.53	CHEMBL2349	Homo sapiens	Inhibition	%	-0.53
	8151151	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-5.73	CHEMBL2349	Homo sapiens	Inhibition	%	-5.73
	8151552	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.15	CHEMBL2349	Homo sapiens	Inhibition	%	2.15
	8151690	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.77	CHEMBL2349	Homo sapiens	Inhibition	%	2.77
	8152068	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.66	CHEMBL2349	Homo sapiens	Inhibition	%	4.66
	8152256	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.92	CHEMBL2349	Homo sapiens	Inhibition	%	3.92
	8152638	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	6.17	CHEMBL2349	Homo sapiens	Inhibition	%	6.17
	8152752	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	6.39	CHEMBL2349	Homo sapiens	Inhibition	%	6.39
	8152976	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.62	CHEMBL2349	Homo sapiens	Inhibition	%	4.62
	8153115	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.47	CHEMBL2349	Homo sapiens	Inhibition	%	3.47
	8153476	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	8.34	CHEMBL2349	Homo sapiens	Inhibition	%	8.34
	8153633	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.52	CHEMBL2349	Homo sapiens	Inhibition	%	1.52
	8153990	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	6.69	CHEMBL2349	Homo sapiens	Inhibition	%	6.69
	8154311	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.71	CHEMBL2349	Homo sapiens	Inhibition	%	3.71
	8154437	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-0.56	CHEMBL2349	Homo sapiens	Inhibition	%	-0.56
	8154820	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.44	CHEMBL2349	Homo sapiens	Inhibition	%	3.44
	8154940	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.41	CHEMBL2349	Homo sapiens	Inhibition	%	1.41
	8155164	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.39	CHEMBL2349	Homo sapiens	Inhibition	%	2.39
	8155340	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.86	CHEMBL2349	Homo sapiens	Inhibition	%	0.86
	8155501	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-5.52	CHEMBL2349	Homo sapiens	Inhibition	%	-5.52
	8155725	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.29	CHEMBL2349	Homo sapiens	Inhibition	%	3.29
	8155903	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.73	CHEMBL2349	Homo sapiens	Inhibition	%	3.73
	8156041	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.64	CHEMBL2349	Homo sapiens	Inhibition	%	3.64
	8156265	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	3.92	CHEMBL2349	Homo sapiens	Inhibition	%	3.92
	8156477	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	4.46	CHEMBL2349	Homo sapiens	Inhibition	%	4.46
	8156627	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.45	CHEMBL2349	Homo sapiens	Inhibition	%	6.45
	8156994	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.08	CHEMBL2349	Homo sapiens	Inhibition	%	7.08
	8157338	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	-2.45	CHEMBL2349	Homo sapiens	Inhibition	%	-2.45
	8157479	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.94	CHEMBL2349	Homo sapiens	Inhibition	%	4.94
	8157833	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.15	CHEMBL2349	Homo sapiens	Inhibition	%	5.15
	8157994	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-1.66	CHEMBL2349	Homo sapiens	Inhibition	%	-1.66
	8158218	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.23	CHEMBL2349	Homo sapiens	Inhibition	%	2.23
	8158244	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	5.26	CHEMBL2349	Homo sapiens	Inhibition	%	5.26
	8158468	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.67	CHEMBL2349	Homo sapiens	Inhibition	%	6.67
	8158626	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.73	CHEMBL2349	Homo sapiens	Inhibition	%	5.73
	8158795	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.06	CHEMBL2349	Homo sapiens	Inhibition	%	3.06
	8159019	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.94	CHEMBL2349	Homo sapiens	Inhibition	%	1.94
	8159154	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.04	CHEMBL2349	Homo sapiens	Inhibition	%	7.04
	8159498	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.99	CHEMBL2349	Homo sapiens	Inhibition	%	1.99
	8159629	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.34	CHEMBL2349	Homo sapiens	Inhibition	%	6.34
	8159853	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	26.93	CHEMBL2349	Homo sapiens	Inhibition	%	26.93
	8159994	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.01	CHEMBL2349	Homo sapiens	Inhibition	%	0.01
	8160355	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.47	CHEMBL2349	Homo sapiens	Inhibition	%	6.47
	8160505	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-4.04	CHEMBL2349	Homo sapiens	Inhibition	%	-4.04
	8160799	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.83	CHEMBL2349	Homo sapiens	Inhibition	%	1.83
	8160949	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.91	CHEMBL2349	Homo sapiens	Inhibition	%	2.91
	8161173	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	6.71	CHEMBL2349	Homo sapiens	Inhibition	%	6.71
	8161316	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	7.04	CHEMBL2349	Homo sapiens	Inhibition	%	7.04
	8161665	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.35	CHEMBL2349	Homo sapiens	Inhibition	%	3.35
	8161803	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	6.94	CHEMBL2349	Homo sapiens	Inhibition	%	6.94
	8162027	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.37	CHEMBL2349	Homo sapiens	Inhibition	%	4.37
	8162157	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	4.8	CHEMBL2349	Homo sapiens	Inhibition	%	4.8
	8162541	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.8	CHEMBL2349	Homo sapiens	Inhibition	%	-0.8
	8162794	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.58	CHEMBL2349	Homo sapiens	Inhibition	%	5.58
	8162942	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	8.94	CHEMBL2349	Homo sapiens	Inhibition	%	8.94
	8163335	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.74	CHEMBL2349	Homo sapiens	Inhibition	%	2.74
	8163469	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	9.85	CHEMBL2349	Homo sapiens	Inhibition	%	9.85
	8163693	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	7.81	CHEMBL2349	Homo sapiens	Inhibition	%	7.81
	8163816	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.28	CHEMBL2349	Homo sapiens	Inhibition	%	3.28
	8164174	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	67.56	CHEMBL2349	Homo sapiens	Inhibition	%	67.56
	8164314	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.42	CHEMBL2349	Homo sapiens	Inhibition	%	-0.42
	8164693	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	7.04	CHEMBL2349	Homo sapiens	Inhibition	%	7.04
	8164837	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-5.93	CHEMBL2349	Homo sapiens	Inhibition	%	-5.93
	8165131	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.37	CHEMBL2349	Homo sapiens	Inhibition	%	5.37
	8165496	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.06	CHEMBL2349	Homo sapiens	Inhibition	%	3.06
	8165639	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	17.1	CHEMBL2349	Homo sapiens	Inhibition	%	17.1
	8165863	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.7	CHEMBL2349	Homo sapiens	Inhibition	%	1.7
	8165989	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.71	CHEMBL2349	Homo sapiens	Inhibition	%	0.71
	8166351	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	8.84	CHEMBL2349	Homo sapiens	Inhibition	%	8.84
	8166481	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.23	CHEMBL2349	Homo sapiens	Inhibition	%	5.23
	8166806	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	0.52	CHEMBL2349	Homo sapiens	Inhibition	%	0.52
	8167118	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.34	CHEMBL2349	Homo sapiens	Inhibition	%	3.34
	8167259	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	32.15	CHEMBL2349	Homo sapiens	Inhibition	%	32.15
	8167483	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.83	CHEMBL2349	Homo sapiens	Inhibition	%	5.83
	8167647	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.46	CHEMBL2349	Homo sapiens	Inhibition	%	1.46
	8168004	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	12.63	CHEMBL2349	Homo sapiens	Inhibition	%	12.63
	8168128	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.63	CHEMBL2349	Homo sapiens	Inhibition	%	0.63
	8168493	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.28	CHEMBL2349	Homo sapiens	Inhibition	%	5.28
	8168629	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-1.13	CHEMBL2349	Homo sapiens	Inhibition	%	-1.13
	8168853	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-4.36	CHEMBL2349	Homo sapiens	Inhibition	%	-4.36
	8169017	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	22.19	CHEMBL2349	Homo sapiens	Inhibition	%	22.19
	8169159	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.59	CHEMBL2349	Homo sapiens	Inhibition	%	3.59
	8169383	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	-0.4	CHEMBL2349	Homo sapiens	Inhibition	%	-0.4
	8169463	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.8	CHEMBL2349	Homo sapiens	Inhibition	%	3.8
	8169687	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.35	CHEMBL2349	Homo sapiens	Inhibition	%	8.35
	8169821	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	6.84	CHEMBL2349	Homo sapiens	Inhibition	%	6.84
	8170190	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	-1.63	CHEMBL2349	Homo sapiens	Inhibition	%	-1.63
	8170315	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.6	CHEMBL2349	Homo sapiens	Inhibition	%	3.6
	8170679	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	4.03	CHEMBL2349	Homo sapiens	Inhibition	%	4.03
	8170814	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.95	CHEMBL2349	Homo sapiens	Inhibition	%	4.95
	8171038	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.16	CHEMBL2349	Homo sapiens	Inhibition	%	4.16
	8171235	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.27	CHEMBL2349	Homo sapiens	Inhibition	%	2.27
	8171452	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	1.77	CHEMBL2349	Homo sapiens	Inhibition	%	1.77
	8171817	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	6.91	CHEMBL2349	Homo sapiens	Inhibition	%	6.91
	8171970	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.06	CHEMBL2349	Homo sapiens	Inhibition	%	2.06
	8172326	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	7.44	CHEMBL2349	Homo sapiens	Inhibition	%	7.44
	8172454	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.08	CHEMBL2349	Homo sapiens	Inhibition	%	2.08
	8172678	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.35	CHEMBL2349	Homo sapiens	Inhibition	%	-0.35
	8172820	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.16	CHEMBL2349	Homo sapiens	Inhibition	%	2.16
	8173180	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.76	CHEMBL2349	Homo sapiens	Inhibition	%	-2.76
	8173345	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.48	CHEMBL2349	Homo sapiens	Inhibition	%	5.48
	8173710	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.01	CHEMBL2349	Homo sapiens	Inhibition	%	4.01
	8174021	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	23.98	CHEMBL2349	Homo sapiens	Inhibition	%	23.98
	8174153	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.23	CHEMBL2349	Homo sapiens	Inhibition	%	4.23
	8174525	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.3	CHEMBL2349	Homo sapiens	Inhibition	%	2.3
	8174647	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.88	CHEMBL2349	Homo sapiens	Inhibition	%	2.88
	8174871	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.66	CHEMBL2349	Homo sapiens	Inhibition	%	3.66
	8175014	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	6.94	CHEMBL2349	Homo sapiens	Inhibition	%	6.94
	8175374	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.83	CHEMBL2349	Homo sapiens	Inhibition	%	3.83
	8175630	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	18.69	CHEMBL2349	Homo sapiens	Inhibition	%	18.69
	8175793	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.44	CHEMBL2349	Homo sapiens	Inhibition	%	2.44
	8176170	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.79	CHEMBL2349	Homo sapiens	Inhibition	%	6.79
	8176319	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.7	CHEMBL2349	Homo sapiens	Inhibition	%	1.7
	8176543	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.06	CHEMBL2349	Homo sapiens	Inhibition	%	2.06
	8176675	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	21.41	CHEMBL2349	Homo sapiens	Inhibition	%	21.41
	8177029	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	3.4	CHEMBL2349	Homo sapiens	Inhibition	%	3.4
	8177171	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	4.78	CHEMBL2349	Homo sapiens	Inhibition	%	4.78
	8177533	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	9.06	CHEMBL2349	Homo sapiens	Inhibition	%	9.06
	8177697	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	7.43	CHEMBL2349	Homo sapiens	Inhibition	%	7.43
	8177921	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.3	CHEMBL2349	Homo sapiens	Inhibition	%	6.3
	8178061	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-0.09	CHEMBL2349	Homo sapiens	Inhibition	%	-0.09
	8178373	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.94	CHEMBL2349	Homo sapiens	Inhibition	%	2.94
	8178500	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.97	CHEMBL2349	Homo sapiens	Inhibition	%	6.97
	8178724	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.34	CHEMBL2349	Homo sapiens	Inhibition	%	5.34
	8178873	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-1.04	CHEMBL2349	Homo sapiens	Inhibition	%	-1.04
	8179220	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	0.88	CHEMBL2349	Homo sapiens	Inhibition	%	0.88
	8179364	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.99	CHEMBL2349	Homo sapiens	Inhibition	%	4.99
	8179725	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.93	CHEMBL2349	Homo sapiens	Inhibition	%	1.93
	8179982	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.18	CHEMBL2349	Homo sapiens	Inhibition	%	6.18
	8180136	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.5	CHEMBL2349	Homo sapiens	Inhibition	%	2.5
	8180360	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.24	CHEMBL2349	Homo sapiens	Inhibition	%	2.24
	8180516	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.79	CHEMBL2349	Homo sapiens	Inhibition	%	4.79
	8180888	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	13.82	CHEMBL2349	Homo sapiens	Inhibition	%	13.82
	8181021	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	5.57	CHEMBL2349	Homo sapiens	Inhibition	%	5.57
	8181376	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-0.73	CHEMBL2349	Homo sapiens	Inhibition	%	-0.73
	8181516	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.82	CHEMBL2349	Homo sapiens	Inhibition	%	2.82
	8181740	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	5.27	CHEMBL2349	Homo sapiens	Inhibition	%	5.27
	8181879	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	39.76	CHEMBL2349	Homo sapiens	Inhibition	%	39.76
	8182266	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.79	CHEMBL2349	Homo sapiens	Inhibition	%	5.79
	8182406	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.81	CHEMBL2349	Homo sapiens	Inhibition	%	3.81
	8182722	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.02	CHEMBL2349	Homo sapiens	Inhibition	%	-0.02
	8183068	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	6.87	CHEMBL2349	Homo sapiens	Inhibition	%	6.87
	8183217	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	2.69	CHEMBL2349	Homo sapiens	Inhibition	%	2.69
	8183570	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.59	CHEMBL2349	Homo sapiens	Inhibition	%	0.59
	8183712	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	11.43	CHEMBL2349	Homo sapiens	Inhibition	%	11.43
	8183936	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	5.9	CHEMBL2349	Homo sapiens	Inhibition	%	5.9
	8184072	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.35	CHEMBL2349	Homo sapiens	Inhibition	%	1.35
	8184338	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	9.48	CHEMBL2349	Homo sapiens	Inhibition	%	9.48
	8184709	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.18	CHEMBL2349	Homo sapiens	Inhibition	%	2.18
	8184866	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	4.66	CHEMBL2349	Homo sapiens	Inhibition	%	4.66
	8185239	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.18	CHEMBL2349	Homo sapiens	Inhibition	%	-0.18
	8185370	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.16	CHEMBL2349	Homo sapiens	Inhibition	%	7.16
	8185594	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.8	CHEMBL2349	Homo sapiens	Inhibition	%	5.8
	8185725	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	19.6	CHEMBL2349	Homo sapiens	Inhibition	%	19.6
	8186088	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.5	CHEMBL2349	Homo sapiens	Inhibition	%	4.5
	8186229	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.94	CHEMBL2349	Homo sapiens	Inhibition	%	4.94
	8186453	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	9.5	CHEMBL2349	Homo sapiens	Inhibition	%	9.5
	8186617	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.25	CHEMBL2349	Homo sapiens	Inhibition	%	7.25
	8186756	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.35	CHEMBL2349	Homo sapiens	Inhibition	%	0.35
	8186980	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.64	CHEMBL2349	Homo sapiens	Inhibition	%	4.64
	8187078	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.43	CHEMBL2349	Homo sapiens	Inhibition	%	2.43
	8187426	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.32	CHEMBL2349	Homo sapiens	Inhibition	%	6.32
	8187574	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.05	CHEMBL2349	Homo sapiens	Inhibition	%	-0.05
	8187798	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.56	CHEMBL2349	Homo sapiens	Inhibition	%	3.56
	8187927	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.97	CHEMBL2349	Homo sapiens	Inhibition	%	6.97
	8188294	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	8.4	CHEMBL2349	Homo sapiens	Inhibition	%	8.4
	8188429	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	1.57	CHEMBL2349	Homo sapiens	Inhibition	%	1.57
	8188653	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.21	CHEMBL2349	Homo sapiens	Inhibition	%	2.21
	8188703	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	7.21	CHEMBL2349	Homo sapiens	Inhibition	%	7.21
	8188927	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	9.87	CHEMBL2349	Homo sapiens	Inhibition	%	9.87
	8189075	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.14	CHEMBL2349	Homo sapiens	Inhibition	%	-0.14
	8189231	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	0.54	CHEMBL2349	Homo sapiens	Inhibition	%	0.54
	8189455	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.62	CHEMBL2349	Homo sapiens	Inhibition	%	5.62
	8189604	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-1.04	CHEMBL2349	Homo sapiens	Inhibition	%	-1.04
	8189960	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	6.86	CHEMBL2349	Homo sapiens	Inhibition	%	6.86
	8190092	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.87	CHEMBL2349	Homo sapiens	Inhibition	%	4.87
	8190316	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.85	CHEMBL2349	Homo sapiens	Inhibition	%	3.85
	8190456	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.49	CHEMBL2349	Homo sapiens	Inhibition	%	5.49
	8190817	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	4.56	CHEMBL2349	Homo sapiens	Inhibition	%	4.56
	8190981	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.69	CHEMBL2349	Homo sapiens	Inhibition	%	4.69
	8191343	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.59	CHEMBL2349	Homo sapiens	Inhibition	%	1.59
	8191439	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.42	CHEMBL2349	Homo sapiens	Inhibition	%	0.42
	8191663	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.74	CHEMBL2349	Homo sapiens	Inhibition	%	1.74
	8191785	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	8.34	CHEMBL2349	Homo sapiens	Inhibition	%	8.34
	8192158	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.53	CHEMBL2349	Homo sapiens	Inhibition	%	0.53
	8192287	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.12	CHEMBL2349	Homo sapiens	Inhibition	%	3.12
	8192511	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	9.31	CHEMBL2349	Homo sapiens	Inhibition	%	9.31
	8192655	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.36	CHEMBL2349	Homo sapiens	Inhibition	%	6.36
	8193015	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.61	CHEMBL2349	Homo sapiens	Inhibition	%	0.61
	8193287	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	4.55	CHEMBL2349	Homo sapiens	Inhibition	%	4.55
	8193432	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.57	CHEMBL2349	Homo sapiens	Inhibition	%	1.57
	8193813	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	13.42	CHEMBL2349	Homo sapiens	Inhibition	%	13.42
	8193962	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.65	CHEMBL2349	Homo sapiens	Inhibition	%	-3.65
	8194317	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.48	CHEMBL2349	Homo sapiens	Inhibition	%	5.48
	8194672	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	4.72	CHEMBL2349	Homo sapiens	Inhibition	%	4.72
	8194815	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.48	CHEMBL2349	Homo sapiens	Inhibition	%	5.48
	8195172	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.31	CHEMBL2349	Homo sapiens	Inhibition	%	7.31
	8195336	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.61	CHEMBL2349	Homo sapiens	Inhibition	%	3.61
	8195560	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.94	CHEMBL2349	Homo sapiens	Inhibition	%	2.94
	8195699	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	5.91	CHEMBL2349	Homo sapiens	Inhibition	%	5.91
	8196021	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.23	CHEMBL2349	Homo sapiens	Inhibition	%	-0.23
	8196138	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	3.39	CHEMBL2349	Homo sapiens	Inhibition	%	3.39
	8196362	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.89	CHEMBL2349	Homo sapiens	Inhibition	%	4.89
	8196512	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.39	CHEMBL2349	Homo sapiens	Inhibition	%	4.39
	8196864	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.82	CHEMBL2349	Homo sapiens	Inhibition	%	3.82
	8197005	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	7.42	CHEMBL2349	Homo sapiens	Inhibition	%	7.42
	8197366	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.99	CHEMBL2349	Homo sapiens	Inhibition	%	0.99
	8197641	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.76	CHEMBL2349	Homo sapiens	Inhibition	%	5.76
	8197781	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	-0.8	CHEMBL2349	Homo sapiens	Inhibition	%	-0.8
	8198005	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.21	CHEMBL2349	Homo sapiens	Inhibition	%	1.21
	8198162	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.24	CHEMBL2349	Homo sapiens	Inhibition	%	4.24
	8198300	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.95	CHEMBL2349	Homo sapiens	Inhibition	%	-3.95
	8198524	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.07	CHEMBL2349	Homo sapiens	Inhibition	%	5.07
	8198654	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	7.74	CHEMBL2349	Homo sapiens	Inhibition	%	7.74
	8199009	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.26	CHEMBL2349	Homo sapiens	Inhibition	%	2.26
	8199157	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.65	CHEMBL2349	Homo sapiens	Inhibition	%	5.65
	8199381	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.19	CHEMBL2349	Homo sapiens	Inhibition	%	5.19
	8199515	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	5.59	CHEMBL2349	Homo sapiens	Inhibition	%	5.59
	8199902	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.11	CHEMBL2349	Homo sapiens	Inhibition	%	3.11
	8200040	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.21	CHEMBL2349	Homo sapiens	Inhibition	%	2.21
	8200368	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.85	CHEMBL2349	Homo sapiens	Inhibition	%	0.85
	8200707	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	4.03	CHEMBL2349	Homo sapiens	Inhibition	%	4.03
	8200857	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	1.91	CHEMBL2349	Homo sapiens	Inhibition	%	1.91
	8201211	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	10.07	CHEMBL2349	Homo sapiens	Inhibition	%	10.07
	8201346	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.17	CHEMBL2349	Homo sapiens	Inhibition	%	5.17
	8201570	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.11	CHEMBL2349	Homo sapiens	Inhibition	%	5.11
	8201703	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.33	CHEMBL2349	Homo sapiens	Inhibition	%	-1.33
	8201982	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.72	CHEMBL2349	Homo sapiens	Inhibition	%	4.72
	8202346	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-3.21	CHEMBL2349	Homo sapiens	Inhibition	%	-3.21
	8202513	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.33	CHEMBL2349	Homo sapiens	Inhibition	%	2.33
	8202862	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	8.42	CHEMBL2349	Homo sapiens	Inhibition	%	8.42
	8202992	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.24	CHEMBL2349	Homo sapiens	Inhibition	%	6.24
	8203216	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	7.75	CHEMBL2349	Homo sapiens	Inhibition	%	7.75
	8203347	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.88	CHEMBL2349	Homo sapiens	Inhibition	%	4.88
	8203717	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	4.4	CHEMBL2349	Homo sapiens	Inhibition	%	4.4
	8203851	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	8.15	CHEMBL2349	Homo sapiens	Inhibition	%	8.15
	8204241	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.25	CHEMBL2349	Homo sapiens	Inhibition	%	1.25
	8204378	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	5.58	CHEMBL2349	Homo sapiens	Inhibition	%	5.58
	8204602	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	2.55	CHEMBL2349	Homo sapiens	Inhibition	%	2.55
	8204707	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.51	CHEMBL2349	Homo sapiens	Inhibition	%	0.51
	8205046	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	8.53	CHEMBL2349	Homo sapiens	Inhibition	%	8.53
	8205195	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	6.12	CHEMBL2349	Homo sapiens	Inhibition	%	6.12
	8205419	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	12.24	CHEMBL2349	Homo sapiens	Inhibition	%	12.24
	8205555	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.34	CHEMBL2349	Homo sapiens	Inhibition	%	4.34
	8205918	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.45	CHEMBL2349	Homo sapiens	Inhibition	%	4.45
	8206050	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.4	CHEMBL2349	Homo sapiens	Inhibition	%	-1.4
	8206326	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.64	CHEMBL2349	Homo sapiens	Inhibition	%	4.64
	8206693	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.57	CHEMBL2349	Homo sapiens	Inhibition	%	-2.57
	8206873	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.54	CHEMBL2349	Homo sapiens	Inhibition	%	4.54
	8207097	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.43	CHEMBL2349	Homo sapiens	Inhibition	%	2.43
	8207223	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.42	CHEMBL2349	Homo sapiens	Inhibition	%	5.42
	8207577	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.68	CHEMBL2349	Homo sapiens	Inhibition	%	6.68
	8207709	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	3.28	CHEMBL2349	Homo sapiens	Inhibition	%	3.28
	8208078	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.46	CHEMBL2349	Homo sapiens	Inhibition	%	2.46
	8208210	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	6.55	CHEMBL2349	Homo sapiens	Inhibition	%	6.55
	8208434	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.39	CHEMBL2349	Homo sapiens	Inhibition	%	8.39
	8208600	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.37	CHEMBL2349	Homo sapiens	Inhibition	%	2.37
	8208957	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.1	CHEMBL2349	Homo sapiens	Inhibition	%	4.1
	8209062	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.01	CHEMBL2349	Homo sapiens	Inhibition	%	0.01
	8209286	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.67	CHEMBL2349	Homo sapiens	Inhibition	%	-0.67
	8209402	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.79	CHEMBL2349	Homo sapiens	Inhibition	%	4.79
	8209776	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.77	CHEMBL2349	Homo sapiens	Inhibition	%	2.77
	8209912	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	9.55	CHEMBL2349	Homo sapiens	Inhibition	%	9.55
	8210277	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.9	CHEMBL2349	Homo sapiens	Inhibition	%	4.9
	8210413	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.86	CHEMBL2349	Homo sapiens	Inhibition	%	-4.86
	8210637	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-3.7	CHEMBL2349	Homo sapiens	Inhibition	%	-3.7
	8210672	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.44	CHEMBL2349	Homo sapiens	Inhibition	%	5.44
	8210896	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.11	CHEMBL2349	Homo sapiens	Inhibition	%	5.11
	8211040	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	4.03	CHEMBL2349	Homo sapiens	Inhibition	%	4.03
	8211434	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.96	CHEMBL2349	Homo sapiens	Inhibition	%	4.96
	8211557	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	10.07	CHEMBL2349	Homo sapiens	Inhibition	%	10.07
	8211910	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.34	CHEMBL2349	Homo sapiens	Inhibition	%	7.34
	8212042	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.91	CHEMBL2349	Homo sapiens	Inhibition	%	4.91
	8212266	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.55	CHEMBL2349	Homo sapiens	Inhibition	%	3.55
	8212407	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	6.96	CHEMBL2349	Homo sapiens	Inhibition	%	6.96
	8212764	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.39	CHEMBL2349	Homo sapiens	Inhibition	%	7.39
	8212934	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.22	CHEMBL2349	Homo sapiens	Inhibition	%	1.22
	8213287	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.15	CHEMBL2349	Homo sapiens	Inhibition	%	1.15
	8213615	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.95	CHEMBL2349	Homo sapiens	Inhibition	%	-3.95
	8213728	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.31	CHEMBL2349	Homo sapiens	Inhibition	%	5.31
	8213952	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	3.65	CHEMBL2349	Homo sapiens	Inhibition	%	3.65
	8214099	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.0	CHEMBL2349	Homo sapiens	Inhibition	%	0.0
	8214236	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	6.57	CHEMBL2349	Homo sapiens	Inhibition	%	6.57
	8214460	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	12.95	CHEMBL2349	Homo sapiens	Inhibition	%	12.95
	8214594	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	4.75	CHEMBL2349	Homo sapiens	Inhibition	%	4.75
	8214970	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-1.14	CHEMBL2349	Homo sapiens	Inhibition	%	-1.14
	8215221	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.78	CHEMBL2349	Homo sapiens	Inhibition	%	3.78
	8215374	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.9	CHEMBL2349	Homo sapiens	Inhibition	%	0.9
	8215762	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.49	CHEMBL2349	Homo sapiens	Inhibition	%	2.49
	8215881	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.76	CHEMBL2349	Homo sapiens	Inhibition	%	6.76
	8216105	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	21.14	CHEMBL2349	Homo sapiens	Inhibition	%	21.14
	8216224	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	5.06	CHEMBL2349	Homo sapiens	Inhibition	%	5.06
	8216584	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	6.64	CHEMBL2349	Homo sapiens	Inhibition	%	6.64
	8216722	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.35	CHEMBL2349	Homo sapiens	Inhibition	%	2.35
	8216946	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.66	CHEMBL2349	Homo sapiens	Inhibition	%	2.66
	8217080	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.38	CHEMBL2349	Homo sapiens	Inhibition	%	7.38
	8217254	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.62	CHEMBL2349	Homo sapiens	Inhibition	%	1.62
	8217478	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.32	CHEMBL2349	Homo sapiens	Inhibition	%	0.32
	8217609	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.94	CHEMBL2349	Homo sapiens	Inhibition	%	4.94
	8217934	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-5.8	CHEMBL2349	Homo sapiens	Inhibition	%	-5.8
	8218273	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.28	CHEMBL2349	Homo sapiens	Inhibition	%	5.28
	8218400	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.32	CHEMBL2349	Homo sapiens	Inhibition	%	3.32
	8218767	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	6.42	CHEMBL2349	Homo sapiens	Inhibition	%	6.42
	8218898	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.26	CHEMBL2349	Homo sapiens	Inhibition	%	6.26
	8219122	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.99	CHEMBL2349	Homo sapiens	Inhibition	%	3.99
	8219282	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-3.23	CHEMBL2349	Homo sapiens	Inhibition	%	-3.23
	8219532	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	4.82	CHEMBL2349	Homo sapiens	Inhibition	%	4.82
	8219693	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	4.41	CHEMBL2349	Homo sapiens	Inhibition	%	4.41
	8219917	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.09	CHEMBL2349	Homo sapiens	Inhibition	%	2.09
	8220086	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	5.65	CHEMBL2349	Homo sapiens	Inhibition	%	5.65
	8220439	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	6.27	CHEMBL2349	Homo sapiens	Inhibition	%	6.27
	8220553	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.43	CHEMBL2349	Homo sapiens	Inhibition	%	4.43
	8220777	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.02	CHEMBL2349	Homo sapiens	Inhibition	%	3.02
	8220915	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	9.59	CHEMBL2349	Homo sapiens	Inhibition	%	9.59
	8221275	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.16	CHEMBL2349	Homo sapiens	Inhibition	%	2.16
	8221408	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	6.18	CHEMBL2349	Homo sapiens	Inhibition	%	6.18
	8221797	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.35	CHEMBL2349	Homo sapiens	Inhibition	%	0.35
	8221928	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	10.92	CHEMBL2349	Homo sapiens	Inhibition	%	10.92
	8222250	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.37	CHEMBL2349	Homo sapiens	Inhibition	%	3.37
	8222608	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.88	CHEMBL2349	Homo sapiens	Inhibition	%	4.88
	8222726	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	7.38	CHEMBL2349	Homo sapiens	Inhibition	%	7.38
	8222950	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	2.48	CHEMBL2349	Homo sapiens	Inhibition	%	2.48
	8223094	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	9.75	CHEMBL2349	Homo sapiens	Inhibition	%	9.75
	8223447	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.6	CHEMBL2349	Homo sapiens	Inhibition	%	4.6
	8223608	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.58	CHEMBL2349	Homo sapiens	Inhibition	%	1.58
	8223858	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	5.31	CHEMBL2349	Homo sapiens	Inhibition	%	5.31
	8224244	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	5.9	CHEMBL2349	Homo sapiens	Inhibition	%	5.9
	8224414	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.16	CHEMBL2349	Homo sapiens	Inhibition	%	3.16
	8224773	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	10.29	CHEMBL2349	Homo sapiens	Inhibition	%	10.29
	8225111	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.01	CHEMBL2349	Homo sapiens	Inhibition	%	4.01
	8225245	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	6.63	CHEMBL2349	Homo sapiens	Inhibition	%	6.63
	8225607	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.19	CHEMBL2349	Homo sapiens	Inhibition	%	1.19
	8225742	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	19.91	CHEMBL2349	Homo sapiens	Inhibition	%	19.91
	8225966	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	5.37	CHEMBL2349	Homo sapiens	Inhibition	%	5.37
	8226124	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.71	CHEMBL2349	Homo sapiens	Inhibition	%	-1.71
	8226249	CHEMBL1961990	GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	4.05	CHEMBL2349	Homo sapiens	Inhibition	%	4.05
	8226473	CHEMBL1961991	GSK_PKIS: PHKG2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.05	CHEMBL2349	Homo sapiens	Inhibition	%	2.05
inactive	9553311	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557224	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557225	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	79.43	CHEMBL2349	Homo sapiens	pKi		7.1
inactive	9557226	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557227	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557228	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	398.11	CHEMBL2349	Homo sapiens	pKi		6.4
inactive	9557229	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557230	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557231	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557232	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557233	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557234	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	100.0	CHEMBL2349	Homo sapiens	pKi		7.0
inactive	9557235	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557236	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	158.49	CHEMBL2349	Homo sapiens	pKi		6.8
inactive	9557237	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557238	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOC(=O)C1=c2sc(=Cc3cccs3)c(=O)n2C(N)=C(C#N)C1c1cccs1		CHEMBL1996893	=	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557239	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9557240	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557241	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557242	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557243	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	199.53	CHEMBL2349	Homo sapiens	pKi		6.7
active	9557244	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
active	9557245	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
active	9557246	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
active	9557247	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9557248	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557249	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557250	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	630.96	CHEMBL2349	Homo sapiens	pKi		6.2
inactive	9557251	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557252	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557253	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557254	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557255	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557256	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557257	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9557258	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557259	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557260	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557261	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557262	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557263	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	794.33	CHEMBL2349	Homo sapiens	pKi		6.1
inactive	9557264	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557265	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557266	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	158.49	CHEMBL2349	Homo sapiens	pKi		6.8
inactive	9557267	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557268	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557269	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557270	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557271	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557272	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557273	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557274	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557275	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9557276	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557277	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557278	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557279	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9557280	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557281	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557282	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9557283	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557284	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9557285	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557286	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557287	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557288	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
active	9557289	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557290	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9557291	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557292	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557293	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557294	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557295	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9557296	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557297	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557298	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9557299	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557300	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557301	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557302	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557303	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557304	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557305	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557306	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557307	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9557308	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557309	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557310	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557311	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557312	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557313	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9557314	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557315	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9557316	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557317	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557318	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557319	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557320	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557321	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(c1ccc2[nH]ncc2c1)c1c(NCc2ccc(Cl)cc2Cl)c(=O)c1=O		CHEMBL1987899	=	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557322	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557323	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557324	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557325	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9557326	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557327	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557328	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557329	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557330	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557331	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557332	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557333	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
active	9557334	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9557335	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557336	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557337	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557338	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557339	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9557340	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557341	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557342	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	501.19	CHEMBL2349	Homo sapiens	pKi		6.3
inactive	9557343	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557344	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557345	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557346	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557347	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9557348	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557349	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557350	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557351	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557352	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557353	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557354	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557355	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
active	9557356	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9557357	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557358	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557359	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557360	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557361	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557362	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9557363	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557364	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557365	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557366	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557367	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557368	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557369	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557370	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557371	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557372	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	398.11	CHEMBL2349	Homo sapiens	pKi		6.4
inactive	9557373	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557374	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557375	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557376	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557377	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557378	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557379	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557380	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9557381	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557382	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557383	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557384	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557385	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557386	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557387	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9557388	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9557389	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557390	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9557391	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557392	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9557393	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557394	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557395	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557396	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557397	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	1258.93	CHEMBL2349	Homo sapiens	pKi		5.9
inactive	9557398	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557399	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9557400	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557401	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557402	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557403	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557404	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557405	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557406	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557407	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557408	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557409	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557410	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557411	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557412	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557413	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557414	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557415	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557416	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557417	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9557418	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557419	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557420	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
active	9557421	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	398.11	CHEMBL2349	Homo sapiens	pKi		6.4
inactive	9557422	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557423	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557424	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557425	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9557426	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557427	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557428	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557429	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9557430	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557431	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	794.33	CHEMBL2349	Homo sapiens	pKi		6.1
inactive	9557432	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557433	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557434	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557435	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557436	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557437	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557438	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557439	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557440	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9557441	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557442	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	398.11	CHEMBL2349	Homo sapiens	pKi		6.4
inactive	9557443	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557444	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557445	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	251.19	CHEMBL2349	Homo sapiens	pKi		6.6
active	9557446	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	316.23	CHEMBL2349	Homo sapiens	pKi		6.5
active	9557447	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9557448	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557449	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9557450	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557451	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557452	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9557453	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	199.53	CHEMBL2349	Homo sapiens	pKi		6.7
active	9557454	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	630.96	CHEMBL2349	Homo sapiens	pKi		6.2
active	9557455	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9557456	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9557457	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561375	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561376	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561377	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561378	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561379	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561380	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	251.19	CHEMBL2349	Homo sapiens	pKi		6.6
inactive	9561381	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561382	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561383	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561384	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561385	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561386	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561387	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561388	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	316.23	CHEMBL2349	Homo sapiens	pKi		6.5
inactive	9561389	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561390	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561391	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561392	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561393	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561394	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561395	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561396	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561397	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561398	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561399	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561400	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561401	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561402	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561403	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561404	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561405	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561406	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561407	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561408	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561409	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	316.23	CHEMBL2349	Homo sapiens	pKi		6.5
inactive	9561410	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561411	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561412	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561413	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	125.89	CHEMBL2349	Homo sapiens	pKi		6.9
active	9561414	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9561415	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561416	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561417	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561418	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561419	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561420	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9561421	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561422	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561423	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561424	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561425	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561426	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561427	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561428	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561429	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561430	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561431	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561432	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561433	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9561434	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561435	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561436	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
active	9561437	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	=	Ki	nM	630.96	CHEMBL2349	Homo sapiens	pKi		6.2
inactive	9561438	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561439	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561440	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9561441	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561442	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561443	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561444	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561445	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	251.19	CHEMBL2349	Homo sapiens	pKi		6.6
active	9561446	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	7.943	CHEMBL2349	Homo sapiens	pKi		8.1
inactive	9561447	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561448	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561449	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9561450	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561451	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561452	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561453	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	794.33	CHEMBL2349	Homo sapiens	pKi		6.1
inactive	9561454	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561455	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9561456	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561457	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561458	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561459	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561460	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561461	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561462	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561463	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9561464	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561465	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561466	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561467	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561468	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561469	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561470	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561471	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561472	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561473	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561474	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561475	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561476	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561477	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561478	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561479	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9561480	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561481	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561482	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561483	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	1258.93	CHEMBL2349	Homo sapiens	pKi		5.9
inactive	9561484	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561485	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9561486	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561487	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561488	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561489	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561490	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	158.49	CHEMBL2349	Homo sapiens	pKi		6.8
active	9561491	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9561492	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561493	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561494	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561495	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561496	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561497	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9561498	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561499	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561500	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	794.33	CHEMBL2349	Homo sapiens	pKi		6.1
inactive	9561501	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561502	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9561503	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561504	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561505	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	1258.93	CHEMBL2349	Homo sapiens	pKi		5.9
inactive	9561506	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561507	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9561508	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561509	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561510	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561511	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561512	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561513	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561514	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	316.23	CHEMBL2349	Homo sapiens	pKi		6.5
inactive	9561515	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561516	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561517	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9561518	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561519	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561520	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561521	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561522	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9561523	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561524	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561525	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561526	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561527	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561528	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9561529	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561530	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561531	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9561532	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561533	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561534	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561535	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561536	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561537	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561538	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561539	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561540	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561541	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	794.33	CHEMBL2349	Homo sapiens	pKi		6.1
active	9561542	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
active	9561543	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9561544	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561545	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561546	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561547	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561548	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561549	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561550	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561551	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561552	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561553	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561554	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9561555	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561556	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	12.59	CHEMBL2349	Homo sapiens	pKi		7.9
inactive	9561557	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561558	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561559	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561560	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561561	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561562	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561563	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561564	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561565	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561566	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561567	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561568	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561569	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561570	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561571	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561572	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9561573	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561574	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9561575	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561576	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561577	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	251.19	CHEMBL2349	Homo sapiens	pKi		6.6
inactive	9561578	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561579	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	251.19	CHEMBL2349	Homo sapiens	pKi		6.6
inactive	9561580	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561581	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561582	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561583	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561584	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	501.19	CHEMBL2349	Homo sapiens	pKi		6.3
inactive	9561585	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561586	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561587	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9561588	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561589	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561590	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561591	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9561592	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561593	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561594	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9561595	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9561596	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561597	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561598	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561599	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561600	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561601	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561602	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561603	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561604	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561605	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561606	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9561607	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565527	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565528	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565529	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565530	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9565531	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565532	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565533	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565534	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
active	9565535	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	794.33	CHEMBL2349	Homo sapiens	pKi		6.1
active	9565536	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9565537	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565538	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565539	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565540	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565541	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	1995.26	CHEMBL2349	Homo sapiens	pKi		5.7
inactive	9565542	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565543	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565544	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565545	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565546	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	15.85	CHEMBL2349	Homo sapiens	pKi		7.8
inactive	9565547	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565548	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565549	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565550	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565551	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565552	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565553	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565554	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565555	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	199.53	CHEMBL2349	Homo sapiens	pKi		6.7
inactive	9565556	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565557	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565558	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565559	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565560	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	316.23	CHEMBL2349	Homo sapiens	pKi		6.5
active	9565561	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	251.19	CHEMBL2349	Homo sapiens	pKi		6.6
inactive	9565562	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565563	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
active	9565564	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	794.33	CHEMBL2349	Homo sapiens	pKi		6.1
active	9565565	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9565566	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565567	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565568	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565569	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565570	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9565571	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565572	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565573	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9565574	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565575	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565576	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565577	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9565578	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565579	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565580	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565581	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565582	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565583	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565584	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9565585	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565586	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565587	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565588	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565589	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565590	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565591	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565592	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565593	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9565594	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565595	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565596	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565597	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565598	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565599	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565600	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565601	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565602	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1584.89	CHEMBL2349	Homo sapiens	pKi		5.8
inactive	9565603	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565604	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565605	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565606	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565607	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565608	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	=	Ki	nM	1000.0	CHEMBL2349	Homo sapiens	pKi		6.0
inactive	9565609	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565610	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565611	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565612	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565613	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565614	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565615	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565616	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565617	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565618	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565619	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565620	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565621	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565622	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9565623	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565624	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565625	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565626	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565627	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565628	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565629	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	3981.07	CHEMBL2349	Homo sapiens	pKi		5.4
inactive	9565630	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565631	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	398.11	CHEMBL2349	Homo sapiens	pKi		6.4
inactive	9565632	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565633	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565634	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	2511.89	CHEMBL2349	Homo sapiens	pKi		5.6
inactive	9565635	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565636	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565637	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565638	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565639	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
inactive	9565640	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565641	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	50.12	CHEMBL2349	Homo sapiens	pKi		7.3
inactive	9565642	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
active	9565643	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
active	9565644	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	3162.28	CHEMBL2349	Homo sapiens	pKi		5.5
inactive	9565645	CHEMBL1963696	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PHKG2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	5011.87	CHEMBL2349	Homo sapiens	pKi		5.3
	10839448	CHEMBL2015479	Inhibition of PHKG2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	26.0	CHEMBL2349	Homo sapiens	INH	%	26.0
	12047300	CHEMBL2157325	Inhibition of PhKgamma2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	6.7	CHEMBL2349	Homo sapiens	INH	%	6.7
	12051567	CHEMBL2154707	Inhibition of PhKg2	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	=	IC50	nM	6.1	CHEMBL2349	Homo sapiens	IC50	nM	6.1
	12051589	CHEMBL2154968	Inhibition of PhKg2 at 10 uM	B	CC(C)Oc1cc(-n2cnc3ccc(N[C@@H](C)c4ccc(F)cn4)nc32)n[nH]1		CHEMBL2151321	>	Inhibition	%	30.0	CHEMBL2349	Homo sapiens	INH	%	30.0
	12074648	CHEMBL2161210	Inhibition of PHKG2 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	12172287	CHEMBL2214967	Inhibition of PHKG2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	12183838	CHEMBL2211978	Inhibition of PHKG2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2349	Homo sapiens	pIC50		5.0
	12274074	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	115.0	CHEMBL2349	Homo sapiens	Residual Activity	%	115.0
	12274075	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	100.0	CHEMBL2349	Homo sapiens	Residual Activity	%	100.0
	12274076	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	86.0	CHEMBL2349	Homo sapiens	Residual Activity	%	86.0
	12274077	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12274078	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	104.0	CHEMBL2349	Homo sapiens	Residual Activity	%	104.0
	12274079	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	97.0	CHEMBL2349	Homo sapiens	Residual Activity	%	97.0
	12274080	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	24.0	CHEMBL2349	Homo sapiens	Residual Activity	%	24.0
	12274081	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	104.0	CHEMBL2349	Homo sapiens	Residual Activity	%	104.0
	12274082	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12274083	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12274084	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12274085	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	83.0	CHEMBL2349	Homo sapiens	Residual Activity	%	83.0
	12274086	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12274087	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12274088	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	64.0	CHEMBL2349	Homo sapiens	Residual Activity	%	64.0
	12274089	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	87.0	CHEMBL2349	Homo sapiens	Residual Activity	%	87.0
	12274090	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12274091	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	111.0	CHEMBL2349	Homo sapiens	Residual Activity	%	111.0
	12274092	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	78.0	CHEMBL2349	Homo sapiens	Residual Activity	%	78.0
	12274093	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	41.0	CHEMBL2349	Homo sapiens	Residual Activity	%	41.0
	12274094	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12274095	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12274096	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12274097	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	87.0	CHEMBL2349	Homo sapiens	Residual Activity	%	87.0
	12274098	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	110.0	CHEMBL2349	Homo sapiens	Residual Activity	%	110.0
	12274099	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12274100	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	91.0	CHEMBL2349	Homo sapiens	Residual Activity	%	91.0
	12274101	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	97.0	CHEMBL2349	Homo sapiens	Residual Activity	%	97.0
	12274102	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12274103	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12274104	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12274105	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12274106	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	101.0	CHEMBL2349	Homo sapiens	Residual Activity	%	101.0
	12274107	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12274108	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	91.0	CHEMBL2349	Homo sapiens	Residual Activity	%	91.0
	12274109	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12274110	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	87.0	CHEMBL2349	Homo sapiens	Residual Activity	%	87.0
	12274111	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12274112	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	101.0	CHEMBL2349	Homo sapiens	Residual Activity	%	101.0
	12274113	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	77.0	CHEMBL2349	Homo sapiens	Residual Activity	%	77.0
	12274114	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12274115	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12274116	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	1.0	CHEMBL2349	Homo sapiens	Residual Activity	%	1.0
	12274117	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	22.0	CHEMBL2349	Homo sapiens	Residual Activity	%	22.0
	12274118	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	61.0	CHEMBL2349	Homo sapiens	Residual Activity	%	61.0
	12274119	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12274120	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	106.0	CHEMBL2349	Homo sapiens	Residual Activity	%	106.0
	12274121	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	70.0	CHEMBL2349	Homo sapiens	Residual Activity	%	70.0
	12274122	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12274123	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12274124	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	91.0	CHEMBL2349	Homo sapiens	Residual Activity	%	91.0
	12274125	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	97.0	CHEMBL2349	Homo sapiens	Residual Activity	%	97.0
	12274126	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	47.0	CHEMBL2349	Homo sapiens	Residual Activity	%	47.0
	12274127	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL2349	Homo sapiens	Residual Activity	%	82.0
	12274128	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12274129	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	86.0	CHEMBL2349	Homo sapiens	Residual Activity	%	86.0
	12274130	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	101.0	CHEMBL2349	Homo sapiens	Residual Activity	%	101.0
	12274131	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12274132	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12274133	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL2349	Homo sapiens	Residual Activity	%	97.0
	12274134	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12274135	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	44.0	CHEMBL2349	Homo sapiens	Residual Activity	%	44.0
	12274136	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	96.0	CHEMBL2349	Homo sapiens	Residual Activity	%	96.0
	12274137	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	84.0	CHEMBL2349	Homo sapiens	Residual Activity	%	84.0
	12274138	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12274139	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12274140	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	97.0	CHEMBL2349	Homo sapiens	Residual Activity	%	97.0
	12274141	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	84.0	CHEMBL2349	Homo sapiens	Residual Activity	%	84.0
	12274142	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12274143	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12274144	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12274145	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12274146	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	88.0	CHEMBL2349	Homo sapiens	Residual Activity	%	88.0
	12274147	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12274148	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	91.0	CHEMBL2349	Homo sapiens	Residual Activity	%	91.0
	12274149	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12274150	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	85.0	CHEMBL2349	Homo sapiens	Residual Activity	%	85.0
	12274151	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	8.0	CHEMBL2349	Homo sapiens	Residual Activity	%	8.0
	12274152	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	96.0	CHEMBL2349	Homo sapiens	Residual Activity	%	96.0
	12274153	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL2349	Homo sapiens	Residual Activity	%	2.0
	12274154	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12275797	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	100.0	CHEMBL2349	Homo sapiens	Residual Activity	%	100.0
	12275798	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275799	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	101.0	CHEMBL2349	Homo sapiens	Residual Activity	%	101.0
	12275800	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	48.0	CHEMBL2349	Homo sapiens	Residual Activity	%	48.0
	12275801	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12275802	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12275803	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12275804	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL2349	Homo sapiens	Residual Activity	%	96.0
	12275805	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	25.0	CHEMBL2349	Homo sapiens	Residual Activity	%	25.0
	12275806	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	119.0	CHEMBL2349	Homo sapiens	Residual Activity	%	119.0
	12275807	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	104.0	CHEMBL2349	Homo sapiens	Residual Activity	%	104.0
	12275808	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	85.0	CHEMBL2349	Homo sapiens	Residual Activity	%	85.0
	12275809	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	118.0	CHEMBL2349	Homo sapiens	Residual Activity	%	118.0
	12275810	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12275811	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12275812	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	110.0	CHEMBL2349	Homo sapiens	Residual Activity	%	110.0
	12275813	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275814	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275815	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	116.0	CHEMBL2349	Homo sapiens	Residual Activity	%	116.0
	12275816	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12275817	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2349	Homo sapiens	Residual Activity	%	0.0
	12275818	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275819	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12275820	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12275821	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	96.0	CHEMBL2349	Homo sapiens	Residual Activity	%	96.0
	12275822	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	111.0	CHEMBL2349	Homo sapiens	Residual Activity	%	111.0
	12275823	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12275824	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	100.0	CHEMBL2349	Homo sapiens	Residual Activity	%	100.0
	12275825	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	120.0	CHEMBL2349	Homo sapiens	Residual Activity	%	120.0
	12275826	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12275827	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12275828	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12275829	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	87.0	CHEMBL2349	Homo sapiens	Residual Activity	%	87.0
	12275830	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	89.0	CHEMBL2349	Homo sapiens	Residual Activity	%	89.0
	12275831	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12275832	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12275833	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	116.0	CHEMBL2349	Homo sapiens	Residual Activity	%	116.0
	12275834	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	125.0	CHEMBL2349	Homo sapiens	Residual Activity	%	125.0
	12275835	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	134.0	CHEMBL2349	Homo sapiens	Residual Activity	%	134.0
	12275836	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	104.0	CHEMBL2349	Homo sapiens	Residual Activity	%	104.0
	12275837	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	78.0	CHEMBL2349	Homo sapiens	Residual Activity	%	78.0
	12275838	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	52.0	CHEMBL2349	Homo sapiens	Residual Activity	%	52.0
	12275839	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	106.0	CHEMBL2349	Homo sapiens	Residual Activity	%	106.0
	12275840	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	21.0	CHEMBL2349	Homo sapiens	Residual Activity	%	21.0
	12275841	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	123.0	CHEMBL2349	Homo sapiens	Residual Activity	%	123.0
	12275842	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	122.0	CHEMBL2349	Homo sapiens	Residual Activity	%	122.0
	12275843	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	129.0	CHEMBL2349	Homo sapiens	Residual Activity	%	129.0
	12275844	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275845	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	86.0	CHEMBL2349	Homo sapiens	Residual Activity	%	86.0
	12275846	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	122.0	CHEMBL2349	Homo sapiens	Residual Activity	%	122.0
	12275847	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	122.0	CHEMBL2349	Homo sapiens	Residual Activity	%	122.0
	12275848	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	77.0	CHEMBL2349	Homo sapiens	Residual Activity	%	77.0
	12275849	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275850	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	120.0	CHEMBL2349	Homo sapiens	Residual Activity	%	120.0
	12275851	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	119.0	CHEMBL2349	Homo sapiens	Residual Activity	%	119.0
	12275852	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12275853	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12275854	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	55.0	CHEMBL2349	Homo sapiens	Residual Activity	%	55.0
	12275855	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	102.0	CHEMBL2349	Homo sapiens	Residual Activity	%	102.0
	12275856	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275857	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12275858	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12275859	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	34.0	CHEMBL2349	Homo sapiens	Residual Activity	%	34.0
	12275860	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12275861	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	111.0	CHEMBL2349	Homo sapiens	Residual Activity	%	111.0
	12275862	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12275863	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12275864	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	102.0	CHEMBL2349	Homo sapiens	Residual Activity	%	102.0
	12275865	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12275866	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	86.0	CHEMBL2349	Homo sapiens	Residual Activity	%	86.0
	12275867	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12275868	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	120.0	CHEMBL2349	Homo sapiens	Residual Activity	%	120.0
	12275869	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	97.0	CHEMBL2349	Homo sapiens	Residual Activity	%	97.0
	12275870	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275871	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	88.0	CHEMBL2349	Homo sapiens	Residual Activity	%	88.0
	12275872	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12275873	CHEMBL2219133	Millipore: Percentage of residual kinase activity of PHKG2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	3.0	CHEMBL2349	Homo sapiens	Residual Activity	%	3.0
	12275874	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL2349	Homo sapiens	Residual Activity	%	106.0
	12275875	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12275876	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12275877	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	53.0	CHEMBL2349	Homo sapiens	Residual Activity	%	53.0
	12275878	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12275879	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12275880	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	9.0	CHEMBL2349	Homo sapiens	Residual Activity	%	9.0
	12275881	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12275882	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	111.0	CHEMBL2349	Homo sapiens	Residual Activity	%	111.0
	12275883	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12275884	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12275885	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12275886	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12275887	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12275888	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	22.0	CHEMBL2349	Homo sapiens	Residual Activity	%	22.0
	12275889	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12275890	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	63.0	CHEMBL2349	Homo sapiens	Residual Activity	%	63.0
	12275891	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	96.0	CHEMBL2349	Homo sapiens	Residual Activity	%	96.0
	12275892	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	84.0	CHEMBL2349	Homo sapiens	Residual Activity	%	84.0
	12275893	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	24.0	CHEMBL2349	Homo sapiens	Residual Activity	%	24.0
	12275894	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	96.0	CHEMBL2349	Homo sapiens	Residual Activity	%	96.0
	12275895	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	86.0	CHEMBL2349	Homo sapiens	Residual Activity	%	86.0
	12275896	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275897	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275898	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	119.0	CHEMBL2349	Homo sapiens	Residual Activity	%	119.0
	12275899	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12275900	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	80.0	CHEMBL2349	Homo sapiens	Residual Activity	%	80.0
	12275901	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12275902	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	122.0	CHEMBL2349	Homo sapiens	Residual Activity	%	122.0
	12275903	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12275904	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	102.0	CHEMBL2349	Homo sapiens	Residual Activity	%	102.0
	12275905	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	66.0	CHEMBL2349	Homo sapiens	Residual Activity	%	66.0
	12275906	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	53.0	CHEMBL2349	Homo sapiens	Residual Activity	%	53.0
	12275907	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	89.0	CHEMBL2349	Homo sapiens	Residual Activity	%	89.0
	12275908	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	79.0	CHEMBL2349	Homo sapiens	Residual Activity	%	79.0
	12275909	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	80.0	CHEMBL2349	Homo sapiens	Residual Activity	%	80.0
	12275910	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	81.0	CHEMBL2349	Homo sapiens	Residual Activity	%	81.0
	12275911	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	116.0	CHEMBL2349	Homo sapiens	Residual Activity	%	116.0
	12275912	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	119.0	CHEMBL2349	Homo sapiens	Residual Activity	%	119.0
	12275913	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	78.0	CHEMBL2349	Homo sapiens	Residual Activity	%	78.0
	12275914	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	122.0	CHEMBL2349	Homo sapiens	Residual Activity	%	122.0
	12275915	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275916	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	2.0	CHEMBL2349	Homo sapiens	Residual Activity	%	2.0
	12275917	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	3.0	CHEMBL2349	Homo sapiens	Residual Activity	%	3.0
	12275918	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	45.0	CHEMBL2349	Homo sapiens	Residual Activity	%	45.0
	12275919	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	86.0	CHEMBL2349	Homo sapiens	Residual Activity	%	86.0
	12275920	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12275921	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	39.0	CHEMBL2349	Homo sapiens	Residual Activity	%	39.0
	12275922	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	120.0	CHEMBL2349	Homo sapiens	Residual Activity	%	120.0
	12275923	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	125.0	CHEMBL2349	Homo sapiens	Residual Activity	%	125.0
	12275924	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12275925	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12275926	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	10.0	CHEMBL2349	Homo sapiens	Residual Activity	%	10.0
	12275927	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	49.0	CHEMBL2349	Homo sapiens	Residual Activity	%	49.0
	12275928	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275929	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12275930	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275931	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12275932	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	96.0	CHEMBL2349	Homo sapiens	Residual Activity	%	96.0
	12275933	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	111.0	CHEMBL2349	Homo sapiens	Residual Activity	%	111.0
	12275934	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	83.0	CHEMBL2349	Homo sapiens	Residual Activity	%	83.0
	12275935	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	29.0	CHEMBL2349	Homo sapiens	Residual Activity	%	29.0
	12275936	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	110.0	CHEMBL2349	Homo sapiens	Residual Activity	%	110.0
	12275937	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275938	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	116.0	CHEMBL2349	Homo sapiens	Residual Activity	%	116.0
	12275939	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	85.0	CHEMBL2349	Homo sapiens	Residual Activity	%	85.0
	12275940	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	100.0	CHEMBL2349	Homo sapiens	Residual Activity	%	100.0
	12275941	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12275942	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	50.0	CHEMBL2349	Homo sapiens	Residual Activity	%	50.0
	12275943	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	123.0	CHEMBL2349	Homo sapiens	Residual Activity	%	123.0
	12275944	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	101.0	CHEMBL2349	Homo sapiens	Residual Activity	%	101.0
	12275945	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	80.0	CHEMBL2349	Homo sapiens	Residual Activity	%	80.0
	12275946	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	63.0	CHEMBL2349	Homo sapiens	Residual Activity	%	63.0
	12275947	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	113.0	CHEMBL2349	Homo sapiens	Residual Activity	%	113.0
	12275948	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	54.0	CHEMBL2349	Homo sapiens	Residual Activity	%	54.0
	12275949	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	81.0	CHEMBL2349	Homo sapiens	Residual Activity	%	81.0
	12275950	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	94.0	CHEMBL2349	Homo sapiens	Residual Activity	%	94.0
	12275951	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	2.0	CHEMBL2349	Homo sapiens	Residual Activity	%	2.0
	12275952	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	106.0	CHEMBL2349	Homo sapiens	Residual Activity	%	106.0
	12275953	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL2349	Homo sapiens	Residual Activity	%	0.0
	12275954	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12275955	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12275956	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	71.0	CHEMBL2349	Homo sapiens	Residual Activity	%	71.0
	12275957	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12275958	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	46.0	CHEMBL2349	Homo sapiens	Residual Activity	%	46.0
	12275959	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12275960	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	100.0	CHEMBL2349	Homo sapiens	Residual Activity	%	100.0
	12275961	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	106.0	CHEMBL2349	Homo sapiens	Residual Activity	%	106.0
	12275962	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	100.0	CHEMBL2349	Homo sapiens	Residual Activity	%	100.0
	12275963	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	12.0	CHEMBL2349	Homo sapiens	Residual Activity	%	12.0
	12275964	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	103.0	CHEMBL2349	Homo sapiens	Residual Activity	%	103.0
	12275965	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12275966	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	35.0	CHEMBL2349	Homo sapiens	Residual Activity	%	35.0
	12275967	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	101.0	CHEMBL2349	Homo sapiens	Residual Activity	%	101.0
	12275968	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12275969	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12275970	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12275971	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	111.0	CHEMBL2349	Homo sapiens	Residual Activity	%	111.0
	12275972	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	92.0	CHEMBL2349	Homo sapiens	Residual Activity	%	92.0
	12275973	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	111.0	CHEMBL2349	Homo sapiens	Residual Activity	%	111.0
	12275974	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	70.0	CHEMBL2349	Homo sapiens	Residual Activity	%	70.0
	12275975	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL2349	Homo sapiens	Residual Activity	%	1.0
	12275976	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	117.0	CHEMBL2349	Homo sapiens	Residual Activity	%	117.0
	12275977	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12275978	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	90.0	CHEMBL2349	Homo sapiens	Residual Activity	%	90.0
	12275979	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	75.0	CHEMBL2349	Homo sapiens	Residual Activity	%	75.0
	12275980	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12275981	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	99.0	CHEMBL2349	Homo sapiens	Residual Activity	%	99.0
	12275982	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	110.0	CHEMBL2349	Homo sapiens	Residual Activity	%	110.0
	12275983	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	89.0	CHEMBL2349	Homo sapiens	Residual Activity	%	89.0
	12275984	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL2349	Homo sapiens	Residual Activity	%	91.0
	12275985	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	95.0	CHEMBL2349	Homo sapiens	Residual Activity	%	95.0
	12275986	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	49.0	CHEMBL2349	Homo sapiens	Residual Activity	%	49.0
	12275987	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	87.0	CHEMBL2349	Homo sapiens	Residual Activity	%	87.0
	12275988	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	80.0	CHEMBL2349	Homo sapiens	Residual Activity	%	80.0
	12275989	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12275990	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	69.0	CHEMBL2349	Homo sapiens	Residual Activity	%	69.0
	12275991	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	83.0	CHEMBL2349	Homo sapiens	Residual Activity	%	83.0
	12275992	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	114.0	CHEMBL2349	Homo sapiens	Residual Activity	%	114.0
	12275993	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12275994	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	81.0	CHEMBL2349	Homo sapiens	Residual Activity	%	81.0
	12275995	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	29.0	CHEMBL2349	Homo sapiens	Residual Activity	%	29.0
	12275996	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	33.0	CHEMBL2349	Homo sapiens	Residual Activity	%	33.0
	12275997	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	84.0	CHEMBL2349	Homo sapiens	Residual Activity	%	84.0
	12275998	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	5.0	CHEMBL2349	Homo sapiens	Residual Activity	%	5.0
	12275999	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12276000	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	82.0	CHEMBL2349	Homo sapiens	Residual Activity	%	82.0
	12276001	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	130.0	CHEMBL2349	Homo sapiens	Residual Activity	%	130.0
	12276002	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12276003	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	31.0	CHEMBL2349	Homo sapiens	Residual Activity	%	31.0
	12276004	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	88.0	CHEMBL2349	Homo sapiens	Residual Activity	%	88.0
	12276005	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	107.0	CHEMBL2349	Homo sapiens	Residual Activity	%	107.0
	12276006	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	15.0	CHEMBL2349	Homo sapiens	Residual Activity	%	15.0
	12276007	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	106.0	CHEMBL2349	Homo sapiens	Residual Activity	%	106.0
	12276008	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	91.0	CHEMBL2349	Homo sapiens	Residual Activity	%	91.0
	12276009	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	97.0	CHEMBL2349	Homo sapiens	Residual Activity	%	97.0
	12276010	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12276011	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	72.0	CHEMBL2349	Homo sapiens	Residual Activity	%	72.0
	12276012	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	24.0	CHEMBL2349	Homo sapiens	Residual Activity	%	24.0
	12276013	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	84.0	CHEMBL2349	Homo sapiens	Residual Activity	%	84.0
	12276014	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12276015	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	73.0	CHEMBL2349	Homo sapiens	Residual Activity	%	73.0
	12276016	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	72.0	CHEMBL2349	Homo sapiens	Residual Activity	%	72.0
	12276017	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	4.0	CHEMBL2349	Homo sapiens	Residual Activity	%	4.0
	12276018	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12276019	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	93.0	CHEMBL2349	Homo sapiens	Residual Activity	%	93.0
	12276020	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	70.0	CHEMBL2349	Homo sapiens	Residual Activity	%	70.0
	12276021	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	52.0	CHEMBL2349	Homo sapiens	Residual Activity	%	52.0
	12276022	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	99.0	CHEMBL2349	Homo sapiens	Residual Activity	%	99.0
	12276023	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	105.0	CHEMBL2349	Homo sapiens	Residual Activity	%	105.0
	12276024	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	22.0	CHEMBL2349	Homo sapiens	Residual Activity	%	22.0
	12276025	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	63.0	CHEMBL2349	Homo sapiens	Residual Activity	%	63.0
	12276026	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	109.0	CHEMBL2349	Homo sapiens	Residual Activity	%	109.0
	12276027	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	112.0	CHEMBL2349	Homo sapiens	Residual Activity	%	112.0
	12276028	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	108.0	CHEMBL2349	Homo sapiens	Residual Activity	%	108.0
	12276029	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	75.0	CHEMBL2349	Homo sapiens	Residual Activity	%	75.0
	12276030	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	98.0	CHEMBL2349	Homo sapiens	Residual Activity	%	98.0
	12276031	CHEMBL2219134	Millipore: Percentage of residual kinase activity of PHKG2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	2.0	CHEMBL2349	Homo sapiens	Residual Activity	%	2.0
	12700138	CHEMBL2342675	Inhibition of recombinant PHKG2 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	37.0	CHEMBL2349	Homo sapiens	INH	%	37.0
	12727671	CHEMBL2351135	Inhibition of PHKgamma2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	102.0	CHEMBL2349	Homo sapiens	Activity	%	102.0
	12728957	CHEMBL2349891	Inhibition of PHKgamma2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL2349	Homo sapiens	Activity	%	105.0
	12729862	CHEMBL2354078	Inhibition of PHKg2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	85.0	CHEMBL2349	Homo sapiens	Activity	%	85.0
	12730100	CHEMBL2351135	Inhibition of PHKgamma2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	89.0	CHEMBL2349	Homo sapiens	Activity	%	89.0
	13351563	CHEMBL2399777	Inhibition of human PhKgamma2 at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12		CHEMBL2397859	=	Inhibition	%	25.0	CHEMBL2349	Homo sapiens	INH	%	25.0
	13374400	CHEMBL2406533	Inhibition of PHKG2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL2349	Homo sapiens	INH	%	2.0
	13434570	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434571	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434572	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434573	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434574	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434575	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434576	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434577	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434578	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434579	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434580	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13434581	CHEMBL2424237	Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	13439940	CHEMBL2429483	Competitive binding affinity to PHKG2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	13445450	CHEMBL2429483	Competitive binding affinity to PHKG2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	90.0	CHEMBL2349	Homo sapiens	INH	%	90.0
	13448505	CHEMBL2429483	Competitive binding affinity to PHKG2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	13448641	CHEMBL2429483	Competitive binding affinity to PHKG2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	13451436	CHEMBL2429483	Competitive binding affinity to PHKG2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	100.0	CHEMBL2349	Homo sapiens	INH	%	100.0
	13454621	CHEMBL2429483	Competitive binding affinity to PHKG2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	83.0	CHEMBL2349	Homo sapiens	INH	%	83.0
	13871788	CHEMBL3101249	Inhibition of human PhKgamma2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	104.0	CHEMBL2349	Homo sapiens	Activity	%	104.0
	14585309	CHEMBL3241825	Inhibition of human PhKgamma2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	111.5	CHEMBL2349	Homo sapiens	Activity	%	111.5
	14713709	CHEMBL3296773	Binding affinity to PHKgamma2 (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	840.0	CHEMBL2349	Homo sapiens	Ki	uM	0.84
	14713731	CHEMBL3296862	Inhibition of PHKgamma2 (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	51.0	CHEMBL2349	Homo sapiens	INH	%	51.0
Not Determined	14713765	CHEMBL3296773	Binding affinity to PHKgamma2 (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Ki			CHEMBL2349	Homo sapiens	Ki		
	14983176	CHEMBL3385023	Inhibition of PHKG2 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	12.0	CHEMBL2349	Homo sapiens	INH	%	12.0
	14984418	CHEMBL3384373	Inhibition of PHKG2 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	-8.0	CHEMBL2349	Homo sapiens	INH	%	-8.0
	15109402	CHEMBL3373412	Inhibition of PHKG2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	32.0	CHEMBL2349	Homo sapiens	Activity	%	32.0
	15754259	CHEMBL3631184	Inhibition of PhKgamma2 (unknown origin) at 1 uM by FRET method	B	N#Cc1ccnc(Nc2cc(C3CCN(C4COC4)CC3)n(C3CCCC3)n2)c1		CHEMBL3629013	=	Inhibition	%	-1.9	CHEMBL2349	Homo sapiens	INH	%	-1.9
	15756864	CHEMBL3630919	Inhibition of PHKg2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	-3.81	CHEMBL2349	Homo sapiens	INH	%	-3.81
	15757859	CHEMBL3630919	Inhibition of PHKg2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	5.98	CHEMBL2349	Homo sapiens	INH	%	5.98
	15758838	CHEMBL3630919	Inhibition of PHKg2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	3.38	CHEMBL2349	Homo sapiens	INH	%	3.38
	16413489	CHEMBL3742691	Inhibition of PHKG2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2349	Homo sapiens	IC50	uM	10.0
	16425405	CHEMBL3751048	Inhibition of PhK gamma2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	1.8	CHEMBL2349	Homo sapiens	INH	%	1.8
	16431954	CHEMBL3748047	Inhibition of human PHKg2 using [KKLNRTLSFAEPG] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2349	Homo sapiens	IC50	uM	10.0
	16451593	CHEMBL3761174	Inhibition of PHKgamma2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-2.9	CHEMBL2349	Homo sapiens	INH	%	-2.9
	16495166	CHEMBL3777745	Inhibition of PHKgamma2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	1.0	CHEMBL2349	Homo sapiens	Activity	%	1.0
	16496085	CHEMBL3777745	Inhibition of PHKgamma2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-3.0	CHEMBL2349	Homo sapiens	Activity	%	-3.0
	16508272	CHEMBL3777745	Inhibition of PHKgamma2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	12.0	CHEMBL2349	Homo sapiens	Activity	%	12.0
	16593513	CHEMBL3812365	Inhibition of human full length recombinant N-terminal GST-tagged PHKG2 expressed in baculovirus at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2349	Homo sapiens	INH	%	40.0
	16614586	CHEMBL3817617	Inhibition of human PHKg2 at 1 uM using [KKLNRTLSFAEPG] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-7.0	CHEMBL2349	Homo sapiens	INH	%	-7.0
	16618130	CHEMBL3816516	Inhibition of full length recombinant human N-terminal GST-tagged PHKgamma2 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	16804141	CHEMBL3869734	Inhibition of human recombinant full length N-terminal GST-tagged PHKG2 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	IC50	nM	226.0	CHEMBL2349	Homo sapiens	IC50	nM	226.0
	16804189	CHEMBL3869780	Inhibition of human recombinant full length N-terminal GST-tagged PHKG2 expressed in baculovirus expression system at 200 nM by Z'-LYTE assay	B	Cn1cc(-c2nc(N[C@@H]3CCCC[C@@H]3N)c(F)c3c2C(=O)NC3)cn1		CHEMBL3979920	=	Inhibition	%	66.0	CHEMBL2349	Homo sapiens	INH	%	66.0
Inactive	17925768	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925769	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925770	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925771	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925772	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925773	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925774	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925775	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925776	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925777	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925778	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925779	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17925780	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1096.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	1096.0
Uncertain	17925781	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	=	Kd	nM	48.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	48.0
Inactive	17925782	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925783	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925784	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Kd	nM	1711.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	1711.0
Inactive	17925785	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925786	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925787	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925788	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925789	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925790	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925791	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925792	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925793	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925794	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925795	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	397.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	397.0
Inactive	17925796	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925797	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925798	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925799	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925800	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925801	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925802	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925803	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925804	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925805	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925806	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925807	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925808	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925809	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925810	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925811	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925812	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925813	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925814	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925815	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925816	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925817	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925818	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925819	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925820	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925821	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925822	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925823	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925824	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925825	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925826	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925827	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925828	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925829	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925830	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925831	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925832	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925833	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925834	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925835	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925836	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925837	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925838	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925839	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	2097.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	2097.0
Inactive	17925840	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925841	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925842	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925843	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	122.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	122.0
Inactive	17925844	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925845	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	3384.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	3384.0
Inactive	17925846	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925847	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925848	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925849	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925850	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925851	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925852	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925853	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925854	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925855	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925856	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925857	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925858	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925859	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925860	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925861	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925862	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925863	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925864	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925865	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925866	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925867	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925868	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925869	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925870	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925871	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925872	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925873	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925874	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925875	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925876	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925877	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925878	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925879	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925880	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925881	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925882	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925883	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925884	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925885	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925886	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925887	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925888	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925889	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17925890	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	18561.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	18561.0
Inactive	17925891	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925892	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925893	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925894	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925895	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925896	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925897	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925898	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925899	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925900	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925901	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	4404.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	4404.0
Inactive	17925902	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925903	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925904	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925905	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925906	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925907	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925908	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925909	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925910	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925911	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925912	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	661.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	661.0
Inactive	17925913	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925914	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925915	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925916	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925917	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925918	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925919	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925920	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17925921	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	331.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	331.0
Active	17925922	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	3504.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	3504.0
Inactive	17925923	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925924	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925925	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925926	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925927	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925928	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925929	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925930	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925931	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925932	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925933	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925934	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	53.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	53.0
Inactive	17925935	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925936	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925937	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925938	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	3366.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	3366.0
Inactive	17925939	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925940	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925941	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925942	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925943	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	2407.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	2407.0
Inactive	17925944	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925945	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925946	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925947	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925948	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925949	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925950	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925951	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	5016.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	5016.0
Inactive	17925952	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925953	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925954	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925955	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925956	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925957	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925958	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925959	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925960	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925961	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925962	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925963	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925964	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925965	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925966	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925967	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925968	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925969	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925970	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925971	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925972	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925973	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925974	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925975	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925976	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925977	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925978	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925979	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925980	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925981	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	7503.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	7503.0
Active	17925982	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	4618.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	4618.0
Inactive	17925983	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17925984	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	3263.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	3263.0
Inactive	17925985	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925986	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925987	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925988	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925989	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925990	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925991	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925992	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925993	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925994	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925995	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925996	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925997	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925998	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17925999	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926000	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926001	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926002	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926003	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Active	17926004	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	1002.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	1002.0
Inactive	17926005	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926006	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926007	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926008	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17926009	CHEMBL3991823	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2349	Homo sapiens	Kd apparent	nM	30000.0
	17979266	CHEMBL3998070	Inhibition of full length recombinant human GST-tagged PHKG2 expressed in baculovirus expression system at 10 uM relative to control	B	CC1=Nc2c(Sc3ccccc3)ncnc2Sc2ccccc21		CHEMBL4061152	=	Inhibition	%	2.0	CHEMBL2349	Homo sapiens	INH	%	2.0
	18114773	CHEMBL4025303	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	18153245	CHEMBL4034453	Inhibition of PHKG2 (unknown origin) labeling at conserved lysine2 at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	>	Inhibition	%	35.0	CHEMBL2349	Homo sapiens	INH	%	35.0
	18203827	CHEMBL4044114	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	98.0	CHEMBL2349	Homo sapiens	Activity	%	98.0
	18253391	CHEMBL4054979	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	67.0	CHEMBL2349	Homo sapiens	Activity	%	67.0
	18253392	CHEMBL4054979	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	18265906	CHEMBL4057356	Inhibition of PhKg2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.7	CHEMBL2349	Homo sapiens	INH	%	1.7
	18266100	CHEMBL4057550	Inhibition of PhKg2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	0.3	CHEMBL2349	Homo sapiens	INH	%	0.3
	18282120	CHEMBL4120075	Inhibition of recombinant full length GST-tagged human PHKgamma2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	1.7	CHEMBL2349	Homo sapiens	INH	%	1.7
	18282439	CHEMBL4120075	Inhibition of recombinant full length GST-tagged human PHKgamma2 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	3.8	CHEMBL2349	Homo sapiens	INH	%	3.8
	18282832	CHEMBL4120417	Inhibition of PhKg2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	1.7	CHEMBL2349	Homo sapiens	INH	%	1.7
	18283052	CHEMBL4120637	Inhibition of PhKg2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-4.0	CHEMBL2349	Homo sapiens	INH	%	-4.0
	18283226	CHEMBL4120811	Inhibition of PhKg2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-1.7	CHEMBL2349	Homo sapiens	INH	%	-1.7
	18379937	CHEMBL4145838	Inhibition of PHKg2 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	8.62	CHEMBL2349	Homo sapiens	INH	%	8.62
	18379989	CHEMBL4145890	Inhibition of PHKg2 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.49	CHEMBL2349	Homo sapiens	IC50	nM	0.49
	18440369	CHEMBL4157193	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	18484325	CHEMBL4185972	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	18484809	CHEMBL4185972	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	88.0	CHEMBL2349	Homo sapiens	Activity	%	88.0
	18501936	CHEMBL4189531	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	N#Cc1ccc(-c2cnc3ccc(-c4ccc(C(=O)N5CCOCC5)cc4)nn23)cc1		CHEMBL4203889	>	Inhibition	%	65.0	CHEMBL2349	Homo sapiens	INH	%	65.0
	18507987	CHEMBL4191107	Inhibition of recombinant human PhKgamma2 (1 to 301 residues) at 1 uM using KKLNRTLSFAEPG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	16.0	CHEMBL2349	Homo sapiens	INH	%	16.0
	18653443	CHEMBL4230182	Inhibition of PHK-gamma2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	-8.0	CHEMBL2349	Homo sapiens	INH	%	-8.0
	18653444	CHEMBL4230182	Inhibition of PHK-gamma2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	4.0	CHEMBL2349	Homo sapiens	INH	%	4.0
	18655363	CHEMBL4230872	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	89.0	CHEMBL2349	Homo sapiens	Activity	%	89.0
	18665429	CHEMBL4233379	Inhibition of PHK-gamma2 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL2349	Homo sapiens	IC50	nM	1000.0
	18674819	CHEMBL4235408	Inhibition of PHKgamma2 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2349	Homo sapiens	Ki	nM	2000.0
	18674820	CHEMBL4235408	Inhibition of PHKgamma2 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2349	Homo sapiens	Ki	nM	2000.0
Not Determined	18674821	CHEMBL4235408	Inhibition of PHKgamma2 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2349	Homo sapiens	Ki		
	18751192	CHEMBL4263901	Inhibition of PHK-GAMMA2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	7.0	CHEMBL2349	Homo sapiens	INH	%	7.0
	18752124	CHEMBL4264461	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	99.0	CHEMBL2349	Homo sapiens	Activity	%	99.0
	18858125	CHEMBL4307971	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
Not Active	18883544	CHEMBL4312747	Activity at human PhKgamma2 at 10 uM	B	CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)[C@H](F)[C@@H]2F		CHEMBL4585668		Activity			CHEMBL2349	Homo sapiens	Activity		
	18892942	CHEMBL4314908	Inhibition of recombinant human PhKgamma2 F290L mutant (1 to 301 residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	92.0	CHEMBL2349	Homo sapiens	Activity	%	92.0
	18919484	CHEMBL4322840	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PHKG2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	71.0	CHEMBL2349	Homo sapiens	Kd	nM	71.0
	18919672	CHEMBL4322840	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PHKG2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	72.0	CHEMBL2349	Homo sapiens	Kd	nM	72.0
	18938199	CHEMBL4327826	Inhibition of human PHKgamma2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	92.16	CHEMBL2349	Homo sapiens	Activity	%	92.16
	18938200	CHEMBL4327826	Inhibition of human PHKgamma2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.94	CHEMBL2349	Homo sapiens	Activity	%	100.94
	18938671	CHEMBL4328190	Inhibition of human PHKgamma2 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2349	Homo sapiens	Activity	%	65.0
	18939055	CHEMBL4328554	Inhibition of human PHKgamma2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.62	CHEMBL2349	Homo sapiens	IC50	10'-10M	6.2
	18958635	CHEMBL4333556	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	72.0	CHEMBL2349	Homo sapiens	Activity	%	72.0
	18964574	CHEMBL4335228	Inhibition of recombinant human PhKgamma2 F290L mutant (1 to 301 residues) assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	107.0	CHEMBL2349	Homo sapiens	Activity	%	107.0
	18964575	CHEMBL4335228	Inhibition of recombinant human PhKgamma2 F290L mutant (1 to 301 residues) assessed as residual activity at 1 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	104.0	CHEMBL2349	Homo sapiens	Activity	%	104.0
	18972041	CHEMBL4337051	Inhibition of recombinant human PhKgamma2 F290L mutant (1 to 301 residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	65.0	CHEMBL2349	Homo sapiens	Activity	%	65.0
	19009320	CHEMBL4345227	Inhibition of wild type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CCN(C)S(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL4531680	>	Inhibition	%	80.0	CHEMBL2349	Homo sapiens	INH	%	80.0
	19021546	CHEMBL4347768	Inhibition of recombinant human PHKG2 at 20 nM using CREBtide as substrate measured after 30 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	10.0	CHEMBL2349	Homo sapiens	INH	%	10.0
	19021547	CHEMBL4347769	Inhibition of recombinant human PHKG2 at 200 nM using CREBtide as substrate measured after 30 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	15.0	CHEMBL2349	Homo sapiens	INH	%	15.0
Not Active	19040099	CHEMBL4352003	Inhibition of recombinant human PhKgamma2 F290L mutant (1 to 301 residues) at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2349	Homo sapiens	INH		
Active	19041232	CHEMBL4352493	Inhibition of human PHKgamma2 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2349	Homo sapiens	INH		
	19059749	CHEMBL4358050	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	19090314	CHEMBL4365888	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	19092064	CHEMBL4366538	Inhibition of human PHKgamma2 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	20.0	CHEMBL2349	Homo sapiens	INH	%	20.0
	19144745	CHEMBL4377761	Inhibition of recombinant human PhKG2 F290L mutant (1 to 301 residues) at 1 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	28.0	CHEMBL2349	Homo sapiens	INH	%	28.0
	19146920	CHEMBL4378872	Inhibition of recombinant human PhKgamma2 F290L mutant (1 to 301 residues) at 10 uM using KKLNRTLSFAEPG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	6.0	CHEMBL2349	Homo sapiens	INH	%	6.0
	19147986	CHEMBL4379287	Inhibition of recombinant human PhKgamma2 F290L (1 to 301 residues) usingKKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2349	Homo sapiens	IC50	uM	10.0
	19155126	CHEMBL4380952	Inhibition of wild type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cn1cc(-c2cncc(-c3ccc(C(N)=O)c(OCC4CCCCC4)c3)c2)cn1		CHEMBL4554869	>	Inhibition	%	95.0	CHEMBL2349	Homo sapiens	INH	%	95.0
	19159577	CHEMBL4382681	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	10.0	CHEMBL2349	Homo sapiens	Activity	%	10.0
	19181128	CHEMBL4387339	Inhibition of recombinant full length human GST-tagged PHKG2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	7.0	CHEMBL2349	Homo sapiens	INH	%	7.0
	19181353	CHEMBL4387339	Inhibition of recombinant full length human GST-tagged PHKG2 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	23.0	CHEMBL2349	Homo sapiens	INH	%	23.0
	19191430	CHEMBL4389400	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	83.0	CHEMBL2349	Homo sapiens	INH	%	83.0
	19192063	CHEMBL4389877	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	100.0	CHEMBL2349	Homo sapiens	INH	%	100.0
	19200319	CHEMBL4391503	Binding affinity to wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	50.0	CHEMBL2349	Homo sapiens	Activity	%	50.0
	19266560	CHEMBL4405510	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2349	Homo sapiens	INH	%	50.0
	20600624	CHEMBL4603576	Inhibition of recombinant full length human N-terminal GST-tagged PHKG2 expressed in baculovirus expression system using serine/threonine-7 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2349	Homo sapiens	IC50	uM	100.0
	22392150	CHEMBL4667245	Inhibition of recombinant human N-terminal GST-tagged full length PHKG2 expressed in baculovirus expression system using Ser/Thr 07 as substrate at 10 uM incubated for 60 mins by Z'-lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.5	CHEMBL2349	Homo sapiens	INH	%	3.5
	22423345	CHEMBL4674248	Inhibition of human PHKgamma2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	96.15	CHEMBL2349	Homo sapiens	Activity	%	96.15
	22423346	CHEMBL4674248	Inhibition of human PHKgamma2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	53.79	CHEMBL2349	Homo sapiens	Activity	%	53.79
	22820542	CHEMBL4716273	Inhibition of recombinant GST-tagged human PHKgamma2 (1 to 301 residues) expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	50.0	CHEMBL2349	Homo sapiens	Activity	%	50.0
	22820543	CHEMBL4716273	Inhibition of recombinant GST-tagged human PHKgamma2 (1 to 301 residues) expressed in Escherichia coli assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	8.0	CHEMBL2349	Homo sapiens	Activity	%	8.0
	22843618	CHEMBL4720604	Inhibition of human PHKgamma2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.336	CHEMBL2349	Homo sapiens	IC50	10^-10M	3.36
	22843962	CHEMBL4720948	Inhibition of human PHKgamma2 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	93.55	CHEMBL2349	Homo sapiens	Activity	%	93.55
	22844820	CHEMBL4721495	Inhibition of wild-type human partial length PHKG2 (M1 to W300 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	90.63	CHEMBL2349	Homo sapiens	Activity	%	90.63
	22952948	CHEMBL4766885	Inhibition of recombinant human PhKgamma2 (1 to 301 residues) assessed as residual activity at 10 uM using KKLNRTLSFAEPG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	23120866	CHEMBL4804462	Inhibition of PHKg2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855542	=	IC50	nM	-27500.0	CHEMBL2349	Homo sapiens	IC50	uM	-27.5
	23120867	CHEMBL4804462	Inhibition of PHKg2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	17300.0	CHEMBL2349	Homo sapiens	IC50	uM	17.3
	23120868	CHEMBL4804462	Inhibition of PHKg2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	24700.0	CHEMBL2349	Homo sapiens	IC50	uM	24.7
	23120869	CHEMBL4804462	Inhibition of PHKg2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4855730	=	IC50	nM	-45400.0	CHEMBL2349	Homo sapiens	IC50	uM	-45.4
	23120870	CHEMBL4804462	Inhibition of PHKg2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4868141	=	IC50	nM	-64000.0	CHEMBL2349	Homo sapiens	IC50	uM	-64.0
	23120871	CHEMBL4804462	Inhibition of PHKg2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-30700.0	CHEMBL2349	Homo sapiens	IC50	uM	-30.7
	23121907	CHEMBL4804644	Inhibition of PHKg2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2349	Homo sapiens	INH	%	0.0
	23121908	CHEMBL4804644	Inhibition of PHKg2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2349	Homo sapiens	INH	%	0.0
	23121909	CHEMBL4804644	Inhibition of PHKg2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2349	Homo sapiens	INH	%	0.0
	23121910	CHEMBL4804644	Inhibition of PHKg2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2349	Homo sapiens	INH	%	0.0
	23121911	CHEMBL4804644	Inhibition of PHKg2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL2349	Homo sapiens	INH	%	0.0
	23121912	CHEMBL4804644	Inhibition of PHKg2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2349	Homo sapiens	INH	%	0.0
	23122734	CHEMBL4805085	Inhibition of human PHKG2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	23123429	CHEMBL4805673	Inhibition of human PHKG2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	83.0	CHEMBL2349	Homo sapiens	Activity	%	83.0
	23123886	CHEMBL4806130	Inhibition of DNA-tagged human PHKG2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2349	Homo sapiens	Activity	%	100.0
	23124948	CHEMBL4806690	Inhibition of human PHKG2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	86.0	CHEMBL2349	Homo sapiens	Activity	%	86.0
	23124949	CHEMBL4806690	Inhibition of human PHKG2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	83.0	CHEMBL2349	Homo sapiens	Activity	%	83.0
	23128437	CHEMBL4807954	Inhibition of PHKG2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL2349	Homo sapiens	Activity	%	75.0
	23128438	CHEMBL4807954	Inhibition of PHKG2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL2349	Homo sapiens	Activity	%	75.0
	23128439	CHEMBL4807954	Inhibition of PHKG2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL2349	Homo sapiens	Activity	%	75.0
	23195922	CHEMBL4819737	Inhibition of human recombinant PHKG2 using ZIPtide at 100 nM direct filter-binding radiometric kinase activity assay relative to control	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(C)cc(=O)n([C@H]3CC[C@@H](NC(=O)C4CCCCC4)CC3)c2n1		CHEMBL4875028	=	Inhibition	%	87.0	CHEMBL2349	Homo sapiens	INH	%	87.0
Not Active	23375333	CHEMBL4886315	phosphorylase kinase, gamma 2 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-3.0	CHEMBL2349	Homo sapiens	% inhibition	%	-3.0
